One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages
The COVID-19 pandemic was officially declared on March 11th, 2020. Since the very beginning, the spread of the virus has been tracked nearly in real-time by worldwide genome sequencing efforts. As of March 2021, more than 830,000 SARS-CoV-2 genomes have been uploaded in GISAID and this wealth of dat...
Saved in:
Published in | Infection, genetics and evolution Vol. 92; p. 104869 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.08.2021
The Authors. Published by Elsevier B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The COVID-19 pandemic was officially declared on March 11th, 2020. Since the very beginning, the spread of the virus has been tracked nearly in real-time by worldwide genome sequencing efforts. As of March 2021, more than 830,000 SARS-CoV-2 genomes have been uploaded in GISAID and this wealth of data allowed researchers to study the evolution of SARS-CoV-2 during this first pandemic year. In parallel, nomenclatures systems, often with poor consistency among each other, have been developed to designate emerging viral lineages. Despite general fears that the virus might mutate to become more virulent or transmissible, SARS-CoV-2 genetic diversity has remained relatively low during the first ~ 8 months of sustained human-to-human transmission. At the end of 2020/beginning of 2021, though, some alarming events started to raise concerns of possible changes in the evolutionary trajectory of the virus. Specifically, three new viral variants associated with extensive transmission have been described as variants of concern (VOC). These variants were first reported in the UK (B.1.1.7), South Africa (B.1.351) and Brazil (P.1). Their designation as VOCs was determined by an increase of local cases and by the high number of amino acid substitutions harboured by these lineages. This latter feature is reminiscent of viral sequences isolated from immunocompromised patients with long-term infection, suggesting a possible causal link. Here we review the events that led to the identification of these lineages, as well as emerging data concerning their possible implications for viral phenotypes, reinfection risk, vaccine efficiency and epidemic potential. Most of the available evidence is, to date, provisional, but still represents a starting point to uncover the potential threat posed by the VOCs. We also stress that genomic surveillance must be strengthened, especially in the wake of the vaccination campaigns.
•After months of human-to-human transmission divergent SARS-CoV-2 lineages have emerged.•The nomenclature is debated, but PANGO lineage names are: B.1.1.7, B.1.351 and P.1.•These lineages display a number of amino acid changes, especially in the S protein.•B.1.1.7, B.1.351 and P.1 may be more transmissible, their effect on disease severity is uncertain.•Some mutations in B.1.351 and P.1 may affect antibody binding or vaccine efficiency. |
---|---|
AbstractList | The COVID-19 pandemic was officially declared on March 11th, 2020. Since the very beginning, the spread of the virus has been tracked nearly in real-time by worldwide genome sequencing efforts. As of March 2021, more than 830,000 SARS-CoV-2 genomes have been uploaded in GISAID and this wealth of data allowed researchers to study the evolution of SARS-CoV-2 during this first pandemic year. In parallel, nomenclatures systems, often with poor consistency among each other, have been developed to designate emerging viral lineages. Despite general fears that the virus might mutate to become more virulent or transmissible, SARS-CoV-2 genetic diversity has remained relatively low during the first ~ 8 months of sustained human-to-human transmission. At the end of 2020/beginning of 2021, though, some alarming events started to raise concerns of possible changes in the evolutionary trajectory of the virus. Specifically, three new viral variants associated with extensive transmission have been described as variants of concern (VOC). These variants were first reported in the UK (B.1.1.7), South Africa (B.1.351) and Brazil (P.1). Their designation as VOCs was determined by an increase of local cases and by the high number of amino acid substitutions harboured by these lineages. This latter feature is reminiscent of viral sequences isolated from immunocompromised patients with long-term infection, suggesting a possible causal link. Here we review the events that led to the identification of these lineages, as well as emerging data concerning their possible implications for viral phenotypes, reinfection risk, vaccine efficiency and epidemic potential. Most of the available evidence is, to date, provisional, but still represents a starting point to uncover the potential threat posed by the VOCs. We also stress that genomic surveillance must be strengthened, especially in the wake of the vaccination campaigns. The COVID-19 pandemic was officially declared on March 11 , 2020. Since the very beginning, the spread of the virus has been tracked nearly in real-time by worldwide genome sequencing efforts. As of March 2021, more than 830,000 SARS-CoV-2 genomes have been uploaded in GISAID and this wealth of data allowed researchers to study the evolution of SARS-CoV-2 during this first pandemic year. In parallel, nomenclatures systems, often with poor consistency among each other, have been developed to designate emerging viral lineages. Despite general fears that the virus might mutate to become more virulent or transmissible, SARS-CoV-2 genetic diversity has remained relatively low during the first ~ 8 months of sustained human-to-human transmission. At the end of 2020/beginning of 2021, though, some alarming events started to raise concerns of possible changes in the evolutionary trajectory of the virus. Specifically, three new viral variants associated with extensive transmission have been described as variants of concern (VOC). These variants were first reported in the UK (B.1.1.7), South Africa (B.1.351) and Brazil (P.1). Their designation as VOCs was determined by an increase of local cases and by the high number of amino acid substitutions harboured by these lineages. This latter feature is reminiscent of viral sequences isolated from immunocompromised patients with long-term infection, suggesting a possible causal link. Here we review the events that led to the identification of these lineages, as well as emerging data concerning their possible implications for viral phenotypes, reinfection risk, vaccine efficiency and epidemic potential. Most of the available evidence is, to date, provisional, but still represents a starting point to uncover the potential threat posed by the VOCs. We also stress that genomic surveillance must be strengthened, especially in the wake of the vaccination campaigns. The COVID-19 pandemic was officially declared on March 11th, 2020. Since the very beginning, the spread of the virus has been tracked nearly in real-time by worldwide genome sequencing efforts. As of March 2021, more than 830,000 SARS-CoV-2 genomes have been uploaded in GISAID and this wealth of data allowed researchers to study the evolution of SARS-CoV-2 during this first pandemic year. In parallel, nomenclatures systems, often with poor consistency among each other, have been developed to designate emerging viral lineages. Despite general fears that the virus might mutate to become more virulent or transmissible, SARS-CoV-2 genetic diversity has remained relatively low during the first ~ 8 months of sustained human-to-human transmission. At the end of 2020/beginning of 2021, though, some alarming events started to raise concerns of possible changes in the evolutionary trajectory of the virus. Specifically, three new viral variants associated with extensive transmission have been described as variants of concern (VOC). These variants were first reported in the UK (B.1.1.7), South Africa (B.1.351) and Brazil (P.1). Their designation as VOCs was determined by an increase of local cases and by the high number of amino acid substitutions harboured by these lineages. This latter feature is reminiscent of viral sequences isolated from immunocompromised patients with long-term infection, suggesting a possible causal link. Here we review the events that led to the identification of these lineages, as well as emerging data concerning their possible implications for viral phenotypes, reinfection risk, vaccine efficiency and epidemic potential. Most of the available evidence is, to date, provisional, but still represents a starting point to uncover the potential threat posed by the VOCs. We also stress that genomic surveillance must be strengthened, especially in the wake of the vaccination campaigns. •After months of human-to-human transmission divergent SARS-CoV-2 lineages have emerged.•The nomenclature is debated, but PANGO lineage names are: B.1.1.7, B.1.351 and P.1.•These lineages display a number of amino acid changes, especially in the S protein.•B.1.1.7, B.1.351 and P.1 may be more transmissible, their effect on disease severity is uncertain.•Some mutations in B.1.351 and P.1 may affect antibody binding or vaccine efficiency. The COVID-19 pandemic was officially declared on March 11 th , 2020. Since the very beginning, the spread of the virus has been tracked nearly in real-time by worldwide genome sequencing efforts. As of March 2021, more than 830,000 SARS-CoV-2 genomes have been uploaded in GISAID and this wealth of data allowed researchers to study the evolution of SARS-CoV-2 during this first pandemic year. In parallel, nomenclatures systems, often with poor consistency among each other, have been developed to designate emerging viral lineages. Despite general fears that the virus might mutate to become more virulent or transmissible, SARS-CoV-2 genetic diversity has remained relatively low during the first ~ 8 months of sustained human-to-human transmission. At the end of 2020/beginning of 2021, though, some alarming events started to raise concerns of possible changes in the evolutionary trajectory of the virus. Specifically, three new viral variants associated with extensive transmission have been described as variants of concern (VOC). These variants were first reported in the UK (B.1.1.7), South Africa (B.1.351) and Brazil (P.1). Their designation as VOCs was determined by an increase of local cases and by the high number of amino acid substitutions harboured by these lineages. This latter feature is reminiscent of viral sequences isolated from immunocompromised patients with long-term infection, suggesting a possible causal link. Here we review the events that led to the identification of these lineages, as well as emerging data concerning their possible implications for viral phenotypes, reinfection risk, vaccine efficiency and epidemic potential. Most of the available evidence is, to date, provisional, but still represents a starting point to uncover the potential threat posed by the VOCs. We also stress that genomic surveillance must be strengthened, especially in the wake of the vaccination campaigns. |
ArticleNumber | 104869 |
Author | González-Candelas, Fernando Phan, Tung Kulkarni-Kale, Urmila Paraskevis, Dimitrios Luciani, Fabio Shaw, Marie-Anne Kimura, Hirokazu Sironi, Manuela |
Author_xml | – sequence: 1 givenname: Fernando surname: González-Candelas fullname: González-Candelas, Fernando organization: Joint Research Unit Infection and Public Health FISABIO-University of Valencia, Institute for Integrative Systems Biology (I2SysBio) and CIBER in Epidemiology and Public Health, Valencia, Spain – sequence: 2 givenname: Marie-Anne surname: Shaw fullname: Shaw, Marie-Anne organization: Leeds Institute of Medical Research at St James's, School of Medicine, University of Leeds, Leeds, United Kingdom – sequence: 3 givenname: Tung surname: Phan fullname: Phan, Tung organization: Division of Clinical Microbiology, University of Pittsburgh and University of Pittsburgh Medical Center, Pittsburgh, PA, USA – sequence: 4 givenname: Urmila surname: Kulkarni-Kale fullname: Kulkarni-Kale, Urmila organization: Bioinformatics Centre, Savitribai Phule Pune University, Ganeshkhind, Pune 411007, Maharashtra, India – sequence: 5 givenname: Dimitrios surname: Paraskevis fullname: Paraskevis, Dimitrios organization: Department of Hygiene Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece – sequence: 6 givenname: Fabio surname: Luciani fullname: Luciani, Fabio organization: University of New South Wales, Sydney 2052, New South Wales, Australia – sequence: 7 givenname: Hirokazu surname: Kimura fullname: Kimura, Hirokazu organization: Department of Health Science, Gunma Paz University Graduate School, Takasaki, Gunma 370-0006, Japan – sequence: 8 givenname: Manuela surname: Sironi fullname: Sironi, Manuela email: manuela.sironi@bp.LNF.it organization: Bioinformatics Unit, Scientific Institute IRCCS E. MEDEA, Bosisio Parini (LC), Italy |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33915216$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kUtvEzEUhS1URB_wDxDyks2kfnuGBVIVlYdUqRIBVkiWx3OTOJqxg-0E9d_jKKGFDStbvueee3y_S3QWYgCEXlMyo4Sq681sAlj5YcYIo_VJtKp7hi6oVLrRTOqz051y0Z6jy5w3hFBNWPsCnXPeUcmoukA_7gPgB7AJ-1AiLmvAWxsGmLx7hxfrmEpTIE0Y9nHcFR8Djku8uPmyaObxe8Nw1WKYIK0gODjUAvzCow9gV5BfoudLO2Z4dTqv0LcPt1_nn5q7-4-f5zd3jROKl0bYjmmheilqvE7YHphkjlulOk2lBMFkpyxYkLwHKznpeS-11Vw6N0gg_Aq9P_pud_0Eg4NQkh3NNvnJpgcTrTf_VoJfm1Xcm5ZoIQmrBm9PBin-3EEuZvLZwTjaAHGXTc1DWqWqvErFUepSzDnB8nEMJeYAxmzMEYw5gDFHMLXtzd8RH5v-kHj6A9RF7T0kk50_LHXwCVwxQ_T_n_AbjXaiJA |
CitedBy_id | crossref_primary_10_1007_s00018_021_04008_0 crossref_primary_10_3390_microorganisms9122518 crossref_primary_10_1371_journal_ppat_1010343 crossref_primary_10_1016_j_jviromet_2021_114428 crossref_primary_10_1128_spectrum_00736_22 crossref_primary_10_1002_rmv_2381 crossref_primary_10_1128_mra_01113_22 crossref_primary_10_3390_v14071522 crossref_primary_10_1186_s12864_023_09539_3 crossref_primary_10_1016_j_jcvp_2022_100118 crossref_primary_10_3390_vaccines9101083 crossref_primary_10_1038_s41598_023_34088_w crossref_primary_10_7759_cureus_26486 crossref_primary_10_3390_vaccines9101106 crossref_primary_10_1016_j_intimp_2022_108565 crossref_primary_10_3390_medicina60060931 crossref_primary_10_1016_j_vaccine_2023_02_005 crossref_primary_10_1080_22221751_2021_2011617 crossref_primary_10_1017_S1047759422000290 crossref_primary_10_1007_s00284_021_02724_1 crossref_primary_10_3389_fmicb_2022_1037455 crossref_primary_10_3390_microorganisms11092336 crossref_primary_10_1016_j_compbiomed_2021_104889 crossref_primary_10_1016_j_ijbiomac_2022_02_034 crossref_primary_10_1080_1040841X_2024_2360407 crossref_primary_10_1016_j_jviromet_2023_114742 crossref_primary_10_1002_hsr2_1127 crossref_primary_10_1007_s40121_022_00604_0 crossref_primary_10_3390_v13112238 crossref_primary_10_1093_bib_bbab382 crossref_primary_10_3389_fviro_2022_889592 crossref_primary_10_1016_j_jcvp_2022_100104 crossref_primary_10_1038_s41598_022_16549_w crossref_primary_10_1590_s1678_9946202264046 crossref_primary_10_1080_07391102_2022_2097955 crossref_primary_10_1093_qjmed_hcab146 crossref_primary_10_1016_j_jim_2021_113182 crossref_primary_10_2174_1381612828666220701160116 crossref_primary_10_3389_fmed_2021_737602 crossref_primary_10_3390_jcm11082100 crossref_primary_10_1038_s41421_021_00357_z crossref_primary_10_1016_j_jclinepi_2023_04_011 crossref_primary_10_3390_v14030545 crossref_primary_10_3390_v14030600 |
Cites_doi | 10.1038/s41586-020-2313-x 10.1177/1176934320965149 10.1126/science.abd2161 10.1126/science.abg3055 10.1038/s41577-020-00434-6 10.1371/journal.ppat.1003565 10.1126/science.abf2946 10.3389/fmicb.2019.03054 10.1016/j.cell.2021.03.028 10.1038/s10038-020-0771-5 10.3389/fcimb.2020.575613 10.1080/22221751.2020.1852058 10.1016/j.meegid.2006.04.002 10.3201/eid2705.210191 10.1038/s41564-020-00838-z 10.1016/j.immuni.2020.07.019 10.1186/s12929-020-00665-8 10.1016/j.coviro.2020.05.010 10.1371/journal.ppat.1000896 10.1038/s41591-020-0897-1 10.3389/fimmu.2020.579250 10.1038/s41586-020-2169-0 10.1093/bioinformatics/btu033 10.1038/d41586-021-00065-4 10.1016/j.meegid.2020.104384 10.3201/eid2702.203767 10.1126/science.abe3261 10.1056/NEJMoa2034577 10.1038/s41564-020-00813-8 10.1038/s41586-020-2521-4 10.1038/s41564-020-0690-4 10.1126/science.abc4730 10.3390/v12030254 10.1016/j.cell.2020.07.012 10.1016/j.cell.2020.06.040 10.1128/JVI.01296-07 10.1128/mBio.02464-14 10.1056/NEJMoa1211721 10.1016/j.tim.2016.09.001 10.1007/s00705-012-1454-0 10.1038/s41579-018-0118-9 10.1038/s41467-020-19818-2 10.1098/rsos.200636 10.1056/NEJMoa2001316 10.1038/s41586-020-2814-7 10.1371/journal.ppat.1009226 10.1056/NEJMc2031364 10.1002/jmv.26778 10.1016/j.jinf.2020.11.021 10.1038/s41591-021-01255-3 10.1126/science.abe5901 10.1016/j.bj.2018.04.007 10.1373/clinchem.2013.203653 10.1016/j.micpath.2020.104236 10.1016/j.cell.2021.03.036 10.1093/ve/veab007 10.1126/science.371.6527.329 10.1038/s41586-020-2608-y 10.1016/S0140-6736(21)00257-9 10.1038/s41586-021-03426-1 10.1126/science.abb2507 10.1038/s41586-020-2012-7 10.1016/j.cell.2020.10.049 10.1371/journal.pone.0246383 10.1093/bib/bbx108 10.1016/j.imbio.2020.152008 10.1038/s41591-020-0997-y 10.1128/mBio.02107-20 10.3389/fmicb.2020.615280 10.1038/s41564-020-0771-4 10.1016/j.meegid.2020.104502 10.1056/NEJMoa2102214 10.1086/651610 10.1126/science.abf9302 10.1038/s41591-020-0820-9 10.1016/j.cell.2020.05.015 10.1128/JVI.03063-14 10.1016/j.cell.2021.01.007 10.1038/s41586-020-2008-3 10.1016/j.ijid.2021.03.005 10.1126/science.abc8169 10.3389/fimmu.2020.585354 10.1007/s00239-001-0064-3 10.1016/j.cell.2020.06.043 10.2807/1560-7917.ES.2020.25.39.2001650 10.1093/ve/veaa061 10.1093/bioinformatics/bty407 10.1126/science.abg6105 10.3390/pathogens9050324 10.1093/ve/veaa034 10.1086/520243 10.1093/nsr/nwaa036 10.1101/gr.266221.120 10.1038/s41564-020-0688-y 10.1371/journal.pbio.3001115 10.1038/s41564-020-0770-5 10.1016/S0140-6736(21)00183-5 10.1038/s41467-020-17687-3 10.3390/v12121438 10.1016/j.meegid.2020.104684 10.1093/infdis/jiab082 10.1016/j.cell.2021.01.037 10.1038/s41564-020-0695-z 10.1016/S0140-6736(20)31757-8 10.1016/S0140-6736(20)30462-1 10.1016/j.meegid.2020.104351 10.3389/fimmu.2020.01748 10.1016/j.cell.2020.09.038 10.1080/22221751.2020.1719902 10.1038/s41591-020-1092-0 10.1056/NEJMoa2006100 10.1002/jmv.25909 10.1128/JVI.79.3.1595-1604.2005 10.2807/1560-7917.ES.2021.26.10.2100130 10.1016/j.cell.2020.11.020 10.1056/NEJMoa2027906 10.1056/NEJMoa030747 10.1126/scitranslmed.abe2555 10.3390/life10080152 10.1016/j.cub.2020.09.030 10.1371/journal.ppat.1009130 10.1038/s41586-020-2639-4 10.2196/25995 10.1016/j.chom.2021.02.003 10.1016/S0140-6736(20)31604-4 10.3390/pathogens9070529 10.1126/science.abg0821 |
ContentType | Journal Article |
Copyright | 2021 The Authors Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved. 2021 The Authors 2021 |
Copyright_xml | – notice: 2021 The Authors – notice: Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved. – notice: 2021 The Authors 2021 |
DBID | 6I. AAFTH CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM |
DOI | 10.1016/j.meegid.2021.104869 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
EISSN | 1567-7257 |
EndPage | 104869 |
ExternalDocumentID | 10_1016_j_meegid_2021_104869 33915216 S1567134821001660 |
Genre | Research Support, Non-U.S. Gov't Journal Article Review |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 29I 4.4 457 4G. 53G 5GY 5VS 6I. 7-5 71M 8P~ AAAJQ AABVA AACTN AAEDT AAEDW AAFTH AAFWJ AAIAV AAIKJ AAKOC AALCJ AALRI AAOAW AAQFI AAQXK AARKO AATLK AAXUO ABBQC ABFNM ABFRF ABGRD ABGSF ABLVK ABMAC ABMZM ABUDA ABXDB ABYKQ ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE ADMUD ADQTV ADUVX AEBSH AEFWE AEHWI AEKER AENEX AEQOU AFKWA AFPKN AFTJW AFXIZ AGEKW AGHFR AGRDE AGUBO AGYEJ AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CBWCG CJTIS CS3 DOVZS DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA GROUPED_DOAJ HVGLF HZ~ IHE J1W KOM LCYCR LUGTX M41 MO0 N9A O-L O9- OAUVE OK1 OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SDF SDG SDP SES SEW SPCBC SSA SSH SSI SSU SSZ T5K UHS UNMZH ~G- 0SF AAHBH AAXKI ADVLN AFJKZ AKRWK CGR CUY CVF ECM EIF NPM AAYXX ACRPL ADNMO CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c463t-4a92746b5470294abe252c3a6697155e42596aeae53bea530b3b57a735ccd5e03 |
IEDL.DBID | AIKHN |
ISSN | 1567-1348 |
IngestDate | Tue Sep 17 21:22:21 EDT 2024 Wed Dec 04 11:21:14 EST 2024 Fri Dec 06 05:23:11 EST 2024 Sat Sep 28 08:17:50 EDT 2024 Fri Feb 23 02:41:00 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | COVID-19 Variants Lineages SARS-CoV-2 Diagnostic tests VACCINES |
Language | English |
License | This is an open access article under the CC BY license. Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c463t-4a92746b5470294abe252c3a6697155e42596aeae53bea530b3b57a735ccd5e03 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S1567134821001660 |
PMID | 33915216 |
PQID | 2520866807 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8074502 proquest_miscellaneous_2520866807 crossref_primary_10_1016_j_meegid_2021_104869 pubmed_primary_33915216 elsevier_sciencedirect_doi_10_1016_j_meegid_2021_104869 |
PublicationCentury | 2000 |
PublicationDate | 2021-08-01 |
PublicationDateYYYYMMDD | 2021-08-01 |
PublicationDate_xml | – month: 08 year: 2021 text: 2021-08-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Infection, genetics and evolution |
PublicationTitleAlternate | Infect Genet Evol |
PublicationYear | 2021 |
Publisher | Elsevier B.V The Authors. Published by Elsevier B.V |
Publisher_xml | – name: Elsevier B.V – name: The Authors. Published by Elsevier B.V |
References | Kidd, Richter, Best, Cumley, Mirza, Percival, Mayhew, Megram, Ashford, White, Moles-Garcia, Crawford, Bosworth, Atabani, Plant, McNally (bb0335) 2021 Larsen, Worobey (bb0400) 2020 Kissler, Fauver, Mack, Tai, Breban, Watkins, Samant, Anderson, Ho, Grubaugh, Grad (bb0345) 2021 Calistri, Amato, Puglia, Cito, Di Giuseppe, Danzetta, Morelli, Di Domenico, Caporale, Scialabba, Portanti, Curini, Perletta, Cammà, Ancora, Savini, Migliorati, D’Alterio, Lorusso (bb0070) 2021 Deng, Garcia-Knight, Khalid, Servellita, Wang, Morris, Sotomayor-Gonzalez, Glasner, Reyes, Gliwa, Reddy, Sanchez San Martin, Federman, Cheng, Balcerek, Taylor, Streithorst, Miller, Kumar, Sreekumar, Chen, Schulze-Gahmen, Taha, Hayashi, Siomoneau, McMahon, Lidsky, Xiao, Green, Hemarajata, Espinosa, Kath, Haw, Bell, Hacker, Hanson, Wadford, Anaya, Ferguson, Lareau, Frankino, Shivram, Wyman, Ott, Andino, Chiu (bb0135) 2021 Young, Fong, Chan, Mak, Ang, Anderson, Lee, Amrun, Lee, Goh, Su, Wei, Kalimuddin, Chai, Pada, Tan, Sun, Parthasarathy, Chen, Barkham, Lin, Maurer-Stroh, Leo, Wang, Renia, Lee, Smith, Lye, Ng (bb0840) 2020; 396 Cyranoski (bb0110) 2021; 589 Liu, Eggo, Kucharski (bb0450) 2020; 395 Al Khatib, Benslimane, Elbashir, Coyle, Al Maslamani, Al-Khal, Al Thani, Yassine (bb0025) 2020; 10 Zhou, Yang, Wang, Hu, Zhang, Zhang, Si, Zhu, Li, Huang, Chen, Chen, Luo, Guo, Jiang, Liu, Chen, Shen, Wang, Zheng, Zhao, Chen, Deng, Liu, Yan, Zhan, Wang, Xiao, Shi (bb0855) 2020; 579 Franco, Gonzalez, Abrego, Carrera, Diaz, Caicedo, Moreno, Chavarria, Gondola, Castillo, Valdespino, Gaitán, Martínez-Mandiche, Hayer, Gonzalez, Lange, Molto, Mojica, Ramos, Mastelari, Cerezo, Moreno, Donnelly, Pascale, Faria, Lopez-Verges, Martinez, Gorgas COVID19 team and Panama COVID19 Laboratory Network (bb0205) 2021; 27 Li, Wu, Nie, Zhang, Hao, Liu, Zhao, Zhang, Liu, Nie, Qin, Wang, Lu, Li, Sun, Liu, Zhang, Li, Huang, Wang (bb0440) 2020; 182 The Lancet (bb0695) 2021; 397 Khan, Cheung (bb0330) 2020; 7 MacLean, Orton, Singer, Robertson (bb0470) 2020; 6 Li, Zheng, Shen, Si, Wang, Wang, Li, Zhang, Zhu, Jiang, Zhao, Wang, Shi, Zhang, Du, Zhou (bb0445) 2020; 9 Rambaut, Holmes, O’Toole, Hill, McCrone, Ruis, du Plessis, Pybus (bb0575) 2020; 5 Wrapp, Wang, Corbett, Goldsmith, Hsieh, Abiona, Graham, McLellan (bb0815) 2020; 367 Gamage, Tan, Chan, Liu, Tan, Ong, Thong, Andiappan, Anderson, Wang, Wang (bb0210) 2020; 16 Long, Liu, Deng, Wu, Deng, Chen, Liao, Qiu, Lin, Cai, Wang, Hu, Ren, Tang, Xu, Yu, Mo, Gong, Zhang, Tian, Hu, Zhang, Xiang, Du, Liu, Lang, Luo, Wu, Cui, Zhou, Zhu, Wang, Xue, Li, Wang, Li, Wang, Niu, Yang, Tang, Zhang, Liu, Li, Zhang, Zhang, Liu, Yuan, Li, Hu, Chen, Huang (bb0460) 2020; 26 Tarke, Sidney, Methot, Zhang, Dan, Goodwin, Rubiro, Sutherland, da Silva Antunes, Frazier, Rawlings, Smith, Peters, Scheuermann, Weiskopf, Crotty, Grifoni, Sette (bb0680) 2021 Vöhringer, Sinnott, Amato, Martincorena, Kwiatkowski, Barrett, Gerstung, The COVID-19 Genomics UK (COG-UK) consortium (bb0770) 2020 Polack, Thomas, Kitchin, Absalon, Gurtman, Lockhart, Perez, Pérez Marc, Moreira, Zerbini, Bailey, Swanson, Roychoudhury, Koury, Li, Kalina, Cooper, Frenck, Hammitt, Türeci, Nell, Schaefer, Ünal, Tresnan, Mather, Dormitzer, Şahin, Jansen, Gruber, C4591001 Clinical Trial Group (bb0560) 2020; 383 Rydyznski Moderbacher, Ramirez, Dan, Grifoni, Hastie, Weiskopf, Belanger, Abbott, Kim, Choi, Kato, Crotty, Kim, Rawlings, Mateus, Tse, Frazier, Baric, Peters, Greenbaum, Ollmann Saphire, Smith, Sette, Crotty (bb0605) 2020; 183 Zhou, Chen, Hu, Li, Song, Liu, Wang, Liu, Yang, Holmes, Hughes, Bi, Shi (bb0850) 2020; 30 Wu, Werner, Moliva, Koch, Choi, Stewart-Jones, Bennett, Boyoglu-Barnum, Shi, Graham, Carfi, Corbett, Seder, Edwards (bb0825) 2021 Hodcroft, Zuber, Nadeau, Crawford, Bloom, Veesler, Vaughan, Comas, Candelas, Stadler, Neher (bb0275) 2020 Tegally, Wilkinson, Giovanetti, Iranzadeh, Fonseca, Giandhari, Doolabh, Pillay, San, Msomi, Mlisana, von Gottberg, Walaza, Allam, Ismail, Mohale, Glass, Engelbrecht, Van Zyl, Preiser, Petruccione, Sigal, Hardie, Marais, Hsiao, Korsman, Davies, Tyers, Mudau, York, Maslo, Goedhals, Abrahams, Laguda-Akingba, Alisoltani-Dehkordi, Godzik, Wibmer, Sewell, Lourenço, Alcantara, Kosakovsky Pond, Weaver, Martin, Lessells, Bhiman, Williamson, de Oliveira (bb0685) 2020 Latinne, Hu, Olival, Zhu, Zhang, Li, Chmura, Field, Zambrana-Torrelio, Epstein, Li, Zhang, Wang, Shi, Daszak (bb0410) 2020; 11 Jenkins, Rambaut, Pybus, Holmes (bb0295) 2002; 54 Avanzato, Matson, Seifert, Pryce, Williamson, Anzick, Barbian, Judson, Fischer, Martens, Bowden, de Wit, Riedo, Munster (bb0045) 2020; 183 Smith, Blanc, Surdel, Vignuzzi, Denison (bb0650) 2013; 9 Ghafari, du Plessis, Pybus, Katzourakis (bb0220) 2020 Laczkó, Hogan, Toulmin, Hicks, Lederer, Gaudette, Castaño, Amanat, Muramatsu, Oguin, Ojha, Zhang, Mu, Parks, Manzoni, Roper, Strohmeier, Tombácz, Arwood, Nachbagauer, Karikó, Greenhouse, Pessaint, Porto, Putman-Taylor, Strasbaugh, Campbell, Lin, Tam, Sempowski, Farzan, Choe, Saunders, Haynes, Andersen, Eisenlohr, Weissman, Krammer, Bates, Allman, Locci, Pardi (bb0385) 2020; 53 Cui, Li, Shi (bb0100) 2019; 17 Zaki, van Boheemen, Bestebroer, Osterhaus, Fouchier (bb0845) 2012; 367 Flanagan, Best, Crawford, Giles, Koirala, Macartney, Russell, Teh, Wen (bb0190) 2020; 11 Popa, Genger, Nicholson, Penz, Schmid, Aberle, Agerer, Lercher, Endler, Colaço, Smyth, Schuster, Grau, Martínez-Jiménez, Pich, Borena, Pawelka, Keszei, Senekowitsch, Laine, Aberle, Redlberger-Fritz, Karolyi, Zoufaly, Maritschnik, Borkovec, Hufnagl, Nairz, Weiss, Wolfinger, von Laer, Superti-Furga, Lopez-Bigas, Puchhammer-Stöckl, Allerberger, Michor, Bock, Bergthaler (bb0565) 2020; 12 Lefever, Pattyn, Hellemans, Vandesompele (bb0415) 2013; 59 Memoli, Hrabal, Hassantoufighi, Jagger, Sheng, Eichelberger, Taubenberger (bb0515) 2010; 201 Sette, Crotty (bb0625) 2021 Van Regenmortel (bb0745) 2007; 7 Lam, Jia, Zhang, Shum, Jiang, Zhu, Tong, Shi, Ni, Liao, Li, Jiang, Wei, Yuan, Zheng, Cui, Li, Pei, Qiang, Cheung, Li, Sun, Qin, Huang, Leung, Holmes, Hu, Guan, Cao (bb0395) 2020 Russi, Bourdin, García, Veaute (bb0600) 2018; 41 Gudbjartsson, Helgason, Jonsson, Magnusson, Melsted, Norddahl, Saemundsdottir, Sigurdsson, Sulem, Agustsdottir, Eiriksdottir, Fridriksdottir, Gardarsdottir, Georgsson, Gretarsdottir, Gudmundsson, Gunnarsdottir, Gylfason, Holm, Jensson, Jonasdottir, Jonsson, Josefsdottir, Kristjansson, Magnusdottir, le Roux, Sigmundsdottir, Sveinbjornsson, Sveinsdottir, Sveinsdottir, Thorarensen, Thorbjornsson, Löve, Masson, Jonsdottir, Möller, Gudnason, Kristinsson, Thorsteinsdottir, Stefansson (bb0260) 2020; 382 Valesano, Rumfelt, Dimcheff, Blair, Fitzsimmons, Petrie, Martin, Lauring (bb0720) 2021 Abu-Raddad, Chemaitelly, Malek, Ahmed, Mohamoud, Younuskunju, Al Kanaani, Al Khal, Al Kuwari, Butt, Coyle, Jeremijenko, Kaleeckal, Latif, Shaik, Abdul Rahim, Yassine, Al Kuwari, Al Romaihi, Al-Thani, Bertollini (bb0010) 2020; 88 Eckerle, Lu, Sperry, Choi, Denison (bb0160) 2007; 81 Vasques Nonaka, Miranda Franco, Gräf, Almeida Mendes, Santana de Aguiar, Giovanetti, Solano de Freitas Souza (bb0760) 2021; 27 Alm, Broberg, Connor, Hodcroft, Komissarov, Maurer-Stroh, Melidou, Neher, O’Toole, Pereyaslov, WHO European Region sequencing laboratories and GISAID EpiCoV group, WHO European Region sequencing laboratories and GISAID EpiCoV group (bb0030) 2020 Garry, Andersen, Gallaher, Lam, Gangaparapu, Latif, Beddingfield, Rambaut, Holmes (bb0215) 2021 Korber, Fischer, Gnanakaran, Yoon, Theiler, Abfalterer, Hengartner, Giorgi, Bhattacharya, Foley, Hastie, Parker, Partridge, Evans, Freeman, de Silva, Sheffield COVID-19 Genomics Group, McDanal, Perez, Tang, Moon-Walker, Whelan, LaBranche, Saphire, Montefiori (bb0360) 2020; 182 Oude Munnink, Sikkema, Nieuwenhuijse, Molenaar, Munger, Molenkamp, van der Spek, Tolsma, Rietveld, Brouwer, Bouwmeester-Vincken, Harders, Hakze-van der Honing, Wegdam-Blans, Bouwstra, GeurtsvanKessel, van der Eijk, Velkers, Smit, Stegeman, van der Poel, Koopmans (bb0550) 2021; 371 Hadfield, Megill, Bell, Huddleston, Potter, Callender, Sagulenko, Bedford, Neher (bb0265) 2018; 34 Starr, Greaney, Addetia, Hannon, Choudhary, Dingens, Li, Bloom (bb0665) 2021 Wells, Letko, Lasso, Ssebide, Nziza, Byarugaba, Navarrete-Macias, Liang, Cranfield, Han, Tingley, Diuk-Wasser, Goldstein, Johnson, Mazet, Chandran, Munster, Gilardi, Anthony (bb0795) 2021; 7 Adam, Wu, Wong, Lau, Tsang, Cauchemez, Leung, Cowling (bb0015) 2020; 26 Jeyanathan, Afkhami, Smaill, Miller, Lichty, Xing (bb0300) 2020; 20 Kalita, Padhi, Zhang, Tripathi (bb0305) 2020; 145 Ziegler, Steininger, Ziegler, Steinmann, Korn, Ensser (bb0860) 2020; 25 Tang, Wu, Li, Song, Yao, Wu, Duan, Zhang, Wang, Qian, Cui, Lu (bb0675) 2020 Thomson, Rosen, Shepherd, Spreafico, da Silva Filipe, Wojcechowskyj, Davis, Piccoli, Pascall, Dillen, Lytras, Czudnochowski, Shah, Meury, Jesudason, De Marco, Li, Bassi, O’Toole, Pinto, Colquhoun, Culap, Jackson, Zatta, Rambaut, Jaconi, Sreenu, Nix, Zhang, Jarrett, Glass, Beltramello, Nomikou, Pizzuto, Tong, Cameroni, Croll, Johnson, Di Iulio, Wickenhagen, Ceschi, Harbison, Mair, Ferrari, Smollett, Sallusto, Carmichael, Garzoni, Nichols, Galli, Hughes, Riva, Ho, Schiuma, Semple, Openshaw, Fadda, Baillie, Chodera, ISARIC4C Investigators, COVID-19 Genomics UK (COG-UK) Consortium, Rihn, Lycett, Virgin, Telenti, Corti, Robertson, Snell (bb0700) 2021; 184 Naveca, da Costa, Nascimento, Souza, Corado, Nascimento, Costa, Duarte, Silva, Mejía, Pessoa, Gonçalves, Brandão, Jesus, Pinto, Silva, Mattos, Abdalla, Santos, Costa-Filho, Wallau, Siqueira, Delatorre, Gräf, Bello, Resende (bb0535) 2021 Sabino, Buss, Carvalho, Prete, Crispim, Fraiji, Pereira, Parag, da Silva Peixoto, Kraemer, Oikawa, Salomon, Cucunuba, Castro, de Souza Santos, Nascimento, Pereira, Ferguson, Pybus, Kucharski, Busch, Dye, Faria (bb0610) 2021 Gómez-Carballa, Bello, Pardo-Seco, Martinón-Torres, Salas (bb0225) 2020; 30 du Plessis, McCrone, Zarebski, Hill, Ruis, Gutierrez, Raghwani, Ashworth, Colquhoun, Connor, Faria, Jackson, Loman, O’Toole, Nicholls, Parag, Scher, Va Liu (10.1016/j.meegid.2021.104869_bb0455) 2021 Grubaugh (10.1016/j.meegid.2021.104869_bb0250) 2020; 5 Polack (10.1016/j.meegid.2021.104869_bb0560) 2020; 383 Davies (10.1016/j.meegid.2021.104869_bb0125) 2021 Smith (10.1016/j.meegid.2021.104869_bb0650) 2013; 9 Koyama (10.1016/j.meegid.2021.104869_bb0370) 2020; 9 Starr (10.1016/j.meegid.2021.104869_bb0665) 2021 Tegally (10.1016/j.meegid.2021.104869_bb0685) 2020 Tomkins-Tinch (10.1016/j.meegid.2021.104869_bb0710) van Dorp (10.1016/j.meegid.2021.104869_bb0735) 2020; 11 Rambaut (10.1016/j.meegid.2021.104869_bb0575) 2020; 5 Gu (10.1016/j.meegid.2021.104869_bb0255) 2020; 369 Ladner (10.1016/j.meegid.2021.104869_bb0390) 2020; 11 Liu (10.1016/j.meegid.2021.104869_bb0450) 2020; 395 Ahmed (10.1016/j.meegid.2021.104869_bb0020) 2020; 12 Eckerle (10.1016/j.meegid.2021.104869_bb0165) 2010; 6 Kidd (10.1016/j.meegid.2021.104869_bb0335) 2021 Hadfield (10.1016/j.meegid.2021.104869_bb0265) 2018; 34 Pybus (10.1016/j.meegid.2021.104869_bb0570) Kiyotani (10.1016/j.meegid.2021.104869_bb0350) 2020; 65 Kirtipal (10.1016/j.meegid.2021.104869_bb0340) 2020; 85 Al Khatib (10.1016/j.meegid.2021.104869_bb0025) 2020; 10 Flanagan (10.1016/j.meegid.2021.104869_bb0190) 2020; 11 Moreno (10.1016/j.meegid.2021.104869_bb0520) Borges (10.1016/j.meegid.2021.104869_bb0060) 2021; 26 Tarke (10.1016/j.meegid.2021.104869_bb0680) 2021 Sironi (10.1016/j.meegid.2021.104869_bb0645) 2020; 84 Hahn (10.1016/j.meegid.2021.104869_bb0270) 2020 Wu (10.1016/j.meegid.2021.104869_bb0820) 2020; 579 Ziegler (10.1016/j.meegid.2021.104869_bb0860) 2020; 25 Volz (10.1016/j.meegid.2021.104869_bb0780) 2021; 184 Grubaugh (10.1016/j.meegid.2021.104869_bb0245) 2020; 182 Khan (10.1016/j.meegid.2021.104869_bb0330) 2020; 7 Korber (10.1016/j.meegid.2021.104869_bb0360) 2020; 182 Leung (10.1016/j.meegid.2021.104869_bb0430) 2021 Naveca (10.1016/j.meegid.2021.104869_bb0535) Russi (10.1016/j.meegid.2021.104869_bb0600) 2018; 41 Chaw (10.1016/j.meegid.2021.104869_bb0085) 2020; 27 Gudbjartsson (10.1016/j.meegid.2021.104869_bb0260) 2020; 382 Sharma (10.1016/j.meegid.2021.104869_bb0630) 2020; 11 Wrapp (10.1016/j.meegid.2021.104869_bb0815) 2020; 367 Volz (10.1016/j.meegid.2021.104869_bb0775) Kupferschmidt (10.1016/j.meegid.2021.104869_bb0380) 2021; 371 McCallum (10.1016/j.meegid.2021.104869_bb0505) 2021 Thomson (10.1016/j.meegid.2021.104869_bb0700) 2021; 184 Gómez-Carballa (10.1016/j.meegid.2021.104869_bb0225) 2020; 30 Sahin (10.1016/j.meegid.2021.104869_bb0615) 2020; 586 MacLean (10.1016/j.meegid.2021.104869_bb0470) 2020; 6 Drosten (10.1016/j.meegid.2021.104869_bb0145) 2003; 348 Muik (10.1016/j.meegid.2021.104869_bb0525) 2021; 371 Sette (10.1016/j.meegid.2021.104869_bb0625) 2021 Olvera (10.1016/j.meegid.2021.104869_bb0540) 2020; 8 Siqueira (10.1016/j.meegid.2021.104869_bb0640) 2020 Katoh (10.1016/j.meegid.2021.104869_bb0320) 2019; 20 van Doremalen (10.1016/j.meegid.2021.104869_bb0725) 2020; 586 Abu-Raddad (10.1016/j.meegid.2021.104869_bb0010) 2020; 88 Kalita (10.1016/j.meegid.2021.104869_bb0305) 2020; 145 Karst (10.1016/j.meegid.2021.104869_bb0310) 2015; 89 Van Regenmortel (10.1016/j.meegid.2021.104869_bb0745) 2007; 7 Long (10.1016/j.meegid.2021.104869_bb0460) 2020; 26 Adam (10.1016/j.meegid.2021.104869_bb0015) 2020; 26 Faulkner (10.1016/j.meegid.2021.104869_bb0180) 2021 Zaki (10.1016/j.meegid.2021.104869_bb0845) 2012; 367 Lemieux (10.1016/j.meegid.2021.104869_bb0420) 2021; 371 Choi (10.1016/j.meegid.2021.104869_bb0090) 2020; 383 Davies (10.1016/j.meegid.2021.104869_bb0120) 2021; 372 Jeyanathan (10.1016/j.meegid.2021.104869_bb0300) 2020; 20 Bazykin (10.1016/j.meegid.2021.104869_bb0050) Folegatti (10.1016/j.meegid.2021.104869_bb0195) 2020; 396 Majra (10.1016/j.meegid.2021.104869_bb0485) 2021; 82 Kissler (10.1016/j.meegid.2021.104869_bb0345) 2021 Kosakovsky Pond (10.1016/j.meegid.2021.104869_bb0365) Zhou (10.1016/j.meegid.2021.104869_bb0855) 2020; 579 Boni (10.1016/j.meegid.2021.104869_bb0055) 2020; 5 Chan (10.1016/j.meegid.2021.104869_bb0080) 2020; 9 Resende (10.1016/j.meegid.2021.104869_bb0585) 2020; 11 Surleac (10.1016/j.meegid.2021.104869_bb0670) 2020; 10 Mulligan (10.1016/j.meegid.2021.104869_bb0530) 2020; 586 Lam (10.1016/j.meegid.2021.104869_bb0395) 2020 Larsen (10.1016/j.meegid.2021.104869_bb0400) da Silva Filipe (10.1016/j.meegid.2021.104869_bb0115) 2021; 6 Avanzato (10.1016/j.meegid.2021.104869_bb0045) 2020; 183 Wu (10.1016/j.meegid.2021.104869_bb0825) 2021 Wibmer (10.1016/j.meegid.2021.104869_bb0800) 2021 MacLean (10.1016/j.meegid.2021.104869_bb0475) 2021; 19 McMinn (10.1016/j.meegid.2021.104869_bb0510) 1999; 29 Spanakis (10.1016/j.meegid.2021.104869_bb0655) 2021 Ko (10.1016/j.meegid.2021.104869_bb0355) 2021; 16 Li (10.1016/j.meegid.2021.104869_bb0435) 2020; 382 Li (10.1016/j.meegid.2021.104869_bb0445) 2020; 9 Eckerle (10.1016/j.meegid.2021.104869_bb0160) 2007; 81 Calistri (10.1016/j.meegid.2021.104869_bb0070) 2021 Larsen (10.1016/j.meegid.2021.104869_bb0405) Li (10.1016/j.meegid.2021.104869_bb0440) 2020; 182 Wells (10.1016/j.meegid.2021.104869_bb0795) 2021; 7 Greaney (10.1016/j.meegid.2021.104869_bb0230) 2021; 29 Vöhringer (10.1016/j.meegid.2021.104869_bb0770) Laczkó (10.1016/j.meegid.2021.104869_bb0385) 2020; 53 Worobey (10.1016/j.meegid.2021.104869_bb0810) 2020; 370 Faria (10.1016/j.meegid.2021.104869_bb0175) 2021 Grifoni (10.1016/j.meegid.2021.104869_bb0240) 2020; 181 Tomaszewski (10.1016/j.meegid.2021.104869_bb0705) 2020; 16 Sheahan (10.1016/j.meegid.2021.104869_bb0635) 2020; 40 van Dorp (10.1016/j.meegid.2021.104869_bb0740) 2020 Lythgoe (10.1016/j.meegid.2021.104869_bb0465) 2021 Franco (10.1016/j.meegid.2021.104869_bb0205) 2021; 27 Hoffmann (10.1016/j.meegid.2021.104869_bb0285) 2021 The Lancet (10.1016/j.meegid.2021.104869_bb0695) 2021; 397 Resende (10.1016/j.meegid.2021.104869_bb0590) Cyranoski (10.1016/j.meegid.2021.104869_bb0110) 2021; 589 Martin (10.1016/j.meegid.2021.104869_bb0490) 2021 Deng (10.1016/j.meegid.2021.104869_bb0135) 2021 Oude Munnink (10.1016/j.meegid.2021.104869_bb0550) 2021; 371 Garry (10.1016/j.meegid.2021.104869_bb0215) Valesano (10.1016/j.meegid.2021.104869_bb0720) 2021 Dellicour (10.1016/j.meegid.2021.104869_bb0130) 2020 Mastriani (10.1016/j.meegid.2021.104869_bb0495) 2021; 2 Rambaut (10.1016/j.meegid.2021.104869_bb0580) Sabino (10.1016/j.meegid.2021.104869_bb0610) 2021 Faria (10.1016/j.meegid.2021.104869_bb0170) Latinne (10.1016/j.meegid.2021.104869_bb0410) 2020; 11 Walsh (10.1016/j.meegid.2021.104869_bb0785) 2020; 383 Aso (10.1016/j.meegid.2021.104869_bb0040) 2019; 10 Jackson (10.1016/j.meegid.2021.104869_bb0290) Seow (10.1016/j.meegid.2021.104869_bb0620) 2020; 5 VanInsberghe (10.1016/j.meegid.2021.104869_bb0750) 2021 Duchene (10.1016/j.meegid.2021.104869_bb0155) 2020; 6 Cui (10.1016/j.meegid.2021.104869_bb0100) 2019; 17 Wang (10.1016/j.meegid.2021.104869_bb0790) 2021 Abdel-Moneim (10.1016/j.meegid.2021.104869_bb0005) 2020; 9 Kemp (10.1016/j.meegid.2021.104869_bb0325) 2020 Letko (10.1016/j.meegid.2021.104869_bb0425) 2020; 5 Stamatakis (10.1016/j.meegid.2021.104869_bb0660) 2014; 30 Young (10.1016/j.meegid.2021.104869_bb0840) 2020; 396 Coronaviridae Study Group of the International Committee on Taxonomy of Viruses (10.1016/j.meegid.2021.104869_bb0095) 2020; 5 Gribble (10.1016/j.meegid.2021.104869_bb0235) 2021; 17 Borges (10.1016/j.meegid.2021.104869_bb0065) Lefever (10.1016/j.meegid.2021.104869_bb0415) 2013; 59 Zhou (10.1016/j.meegid.2021.104869_bb0850) 2020; 30 Memoli (10.1016/j.meegid.2021.104869_bb0515) 2010; 201 Xiao (10.1016/j.meegid.2021.104869_bb0830) 2020; 583 Kasibhatla (10.1016/j.meegid.2021.104869_bb0315) 2020; 92 Rogers (10.1016/j.meegid.2021.104869_bb0595) 2015; 6 Tonkin-Hill (10.1016/j.meegid.2021.104869_bb0715) 2020 Di Giallonardo (10.1016/j.meegid.2021.104869_bb0140) 2020; 12 du Plessis (10.1016/j.meegid.2021.104869_bb0150) 2021 Vijgen (10.1016/j.meegid.2021.104869_bb0765) 2005; 79 Xie (10.1016/j.meegid.2021.104869_bb0835) 2021 van Dorp (10.1016/j.meegid.2021.104869_bb0730) 2020; 83 Ghafari (10.1016/j.meegid.2021.104869_bb0220) Alm (10.1016/j.meegid.2021.104869_bb0030) 2020 Kuhn (10.1016/j.meegid.2021.104869_bb0375) 2013; 158 Jenkins (10.1016/j.meegid.2021.104869_bb0295) 2002; 54 Gamage (10.1016/j.meegid.2021.104869_bb0210) 2020; 16 Vasques Nonaka (10.1016/j.meegid.2021.104869_bb0760) 2021; 27 Tegally (10.1016/j.meegid.2021.104869_bb0690) 2021 Williamson (10.1016/j.meegid.2021.104869_bb0805) 2020; 584 Madhi (10.1016/j.meegid.2021.104869_bb0480) 2021 Oude Munnink (10.1016/j.meegid.2021.104869_bb0545) 2020; 26 Varghese (10.1016/j.meegid.2021.104869_bb0755) 2020; 225 Cunha (10.1016/j.meegid.2021.104869_bb0105) 2020; 11 McCallum (10.1016/j.meegid.2021.104869_bb0500) 2021 Plante (10.1016/j.meegid.2021.104869_bb0555) 2020 Andersen (10.1016/j.meegid.2021.104869_bb0035) 2020; 26 Popa (10.1016/j.meegid.2021.104869_bb0565) 2020; 12 Candido (10.1016/j.meegid.2021.104869_bb0075) 2020; 369 Hodcroft (10.1016/j.meegid.2021.104869_bb0275) 2020 Tang (10.1016/j.meegid.2021.104869_bb0675) 2020 Fischer (10.1016/j.meegid.2021.104869_bb0185) 2021 Hodcroft (10.1016/j.meegid.2021.104869_bb0280) 2021 Rydyznski Moderbacher (10.1016/j.meegid.2021.104869_bb0605) 2020; 183 Forni (10.1016/j.meegid.2021.104869_bb0200) 2017; 25 |
References_xml | – volume: 586 start-page: 578 year: 2020 end-page: 582 ident: bb0725 article-title: ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques publication-title: Nature contributor: fullname: Munster – year: 2020 ident: bb0685 article-title: Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa publication-title: medRxiv contributor: fullname: de Oliveira – year: 2021 ident: bb0520 article-title: Detection of non-B.1.1.7 Spike ∆69/70 sequences (B.1.375) in the United States contributor: fullname: Brito – volume: 367 start-page: 1260 year: 2020 end-page: 1263 ident: bb0815 article-title: Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation publication-title: Science contributor: fullname: McLellan – volume: 30 start-page: 1312 year: 2014 end-page: 1313 ident: bb0660 article-title: RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies publication-title: Bioinformatics contributor: fullname: Stamatakis – volume: 145 start-page: 104236 year: 2020 ident: bb0305 article-title: Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2 publication-title: Microb. Pathog. contributor: fullname: Tripathi – volume: 579 start-page: 265 year: 2020 end-page: 269 ident: bb0820 article-title: A new coronavirus associated with human respiratory disease in China publication-title: Nature contributor: fullname: Zhang – volume: 82 start-page: 36 year: 2021 end-page: 40 ident: bb0485 article-title: SARS-CoV-2 (COVID-19) superspreader events publication-title: J. Infect. contributor: fullname: Stebbing – volume: 20 start-page: 615 year: 2020 end-page: 632 ident: bb0300 article-title: Immunological considerations for COVID-19 vaccine strategies publication-title: Nat. Rev. Immunol. contributor: fullname: Xing – volume: 92 start-page: 1932 year: 2020 end-page: 1937 ident: bb0315 article-title: Understanding evolution of SARS-CoV-2: A perspective from analysis of genetic diversity of RdRp gene publication-title: J. Med. Virol. contributor: fullname: Kulkarni-Kale – volume: 16 year: 2020 ident: bb0210 article-title: Infection of human nasal epithelial cells with SARS-CoV-2 and a 382-nt deletion isolate lacking ORF8 reveals similar viral kinetics and host transcriptional profiles publication-title: PLoS Pathog. contributor: fullname: Wang – year: 2021 ident: bb0125 article-title: Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7 publication-title: Nature. contributor: fullname: Keogh – volume: 6 start-page: 112 year: 2021 end-page: 122 ident: bb0115 article-title: Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland publication-title: Nat. Microbiol. contributor: fullname: Thomson – volume: 11 start-page: 585354 year: 2020 ident: bb0630 article-title: A review of the progress and challenges of developing a vaccine for COVID-19 publication-title: Front. Immunol. contributor: fullname: Triggle – volume: 8 year: 2020 ident: bb0540 article-title: SARS-CoV-2 consensus-sequence and matching overlapping peptides design for COVID19 immune studies and vaccine development publication-title: Vaccines (Basel) contributor: fullname: Brander – year: 2021 ident: bb0455 article-title: Landscape analysis of escape variants identifies SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization publication-title: BioRxiv. contributor: fullname: Whelan – year: 2021 ident: bb0655 article-title: A main event and multiple introductions of SARS-Cov2 initiated the COVID-19 epidemic in Greece publication-title: J. Med. Virol. contributor: fullname: Karakasiliotis – year: 2021 ident: bb0835 article-title: Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera publication-title: bioRxiv contributor: fullname: Shi – year: 2020 ident: bb0220 article-title: Time dependence of SARS-CoV-2 substitution rates contributor: fullname: Katzourakis – year: 2020 ident: bb0740 article-title: Recurrent mutations in SARS-CoV-2 genomes isolated from mink point to rapid host-adaptation publication-title: Cold Spring Harbor Laboratory. contributor: fullname: Balloux – volume: 27 start-page: 73 year: 2020 ident: bb0085 article-title: The origin and underlying driving forces of the SARS-CoV-2 outbreak publication-title: J. Biomed. Sci. contributor: fullname: Wang – year: 2021 ident: bb0180 article-title: Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains publication-title: bioRxiv contributor: fullname: Kassiotis – volume: 40 start-page: 37 year: 2020 end-page: 40 ident: bb0635 article-title: The continued epidemic threat of SARS-CoV-2 and implications for the future of global public health publication-title: Curr. Opin. Virol. contributor: fullname: Frieman – volume: 83 start-page: 104351 year: 2020 ident: bb0730 article-title: Emergence of genomic diversity and recurrent mutations in SARS-CoV-2 publication-title: Infect. Genet. Evol. contributor: fullname: Balloux – volume: 16 year: 2020 ident: bb0705 article-title: New pathways of mutational change in SARS-CoV-2 proteomes involve regions of intrinsic disorder important for virus replication and release publication-title: Evol. Bioinform. Online contributor: fullname: Caetano-Anollés – year: 2021 ident: bb0500 article-title: SARS-CoV-2 immune evasion by variant B.1.427/B.1.429 publication-title: bioRxiv contributor: fullname: Veesler – volume: 7 year: 2021 ident: bb0795 article-title: The evolutionary history of ACE2 usage within the coronavirus subgenus publication-title: Virus Evol. contributor: fullname: Anthony – volume: 81 start-page: 12135 year: 2007 end-page: 12144 ident: bb0160 article-title: High fidelity of murine hepatitis virus replication is decreased in nsp14 exoribonuclease mutants publication-title: J. Virol. contributor: fullname: Denison – volume: 26 start-page: 845 year: 2020 end-page: 848 ident: bb0460 article-title: Antibody responses to SARS-CoV-2 in patients with COVID-19 publication-title: Nat. Med. contributor: fullname: Huang – year: 2021 ident: bb0465 article-title: SARS-CoV-2 within-host diversity and transmission publication-title: Science contributor: fullname: Golubchik – volume: 9 year: 2013 ident: bb0650 article-title: Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics publication-title: PLoS Pathog. contributor: fullname: Denison – volume: 41 start-page: 109 year: 2018 end-page: 117 ident: bb0600 article-title: In silico prediction of T- and B-cell epitopes in PmpD: First step towards to the design of a Chlamydia trachomatis vaccine publication-title: Biomed. J. contributor: fullname: Veaute – volume: 182 start-page: 812 year: 2020 end-page: 827 ident: bb0245 article-title: Making sense of mutation: what D614G means for the COVID-19 pandemic remains unclear publication-title: Cell. contributor: fullname: Rasmussen – volume: 17 start-page: 181 year: 2019 end-page: 192 ident: bb0100 article-title: Origin and evolution of pathogenic coronaviruses publication-title: Nat. Rev. Microbiol. contributor: fullname: Shi – volume: 5 start-page: 529 year: 2020 end-page: 530 ident: bb0250 article-title: We shouldn’t worry when a virus mutates during disease outbreaks publication-title: Nat. Microbiol. contributor: fullname: Holmes – year: 2021 ident: bb0150 article-title: Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK publication-title: Science contributor: fullname: Pybus – volume: 382 start-page: 1199 year: 2020 end-page: 1207 ident: bb0435 article-title: Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia publication-title: N. Engl. J. Med. contributor: fullname: Feng – year: 2021 ident: bb0505 article-title: N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2 publication-title: Cell. contributor: fullname: Veesler – volume: 30 start-page: 1434 year: 2020 end-page: 1448 ident: bb0225 article-title: Mapping genome variation of SARS-CoV-2 worldwide highlights the impact of COVID-19 super-spreaders publication-title: Genome Res. contributor: fullname: Salas – year: 2021 ident: bb0285 article-title: SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies publication-title: Cell contributor: fullname: Pöhlmann – year: 2021 ident: bb0710 article-title: Detection of the recurrent substitution Q677H in the spike protein of SARS-CoV-2 in cases descended from the lineage B.1.429 contributor: fullname: Sabeti – year: 2020 ident: bb0130 article-title: A phylodynamic workflow to rapidly gain insights into the dispersal history and dynamics of SARS-CoV-2 lineages publication-title: Mol. Biol. Evol. contributor: fullname: Maes – volume: 201 start-page: 1397 year: 2010 end-page: 1403 ident: bb0515 article-title: Rapid selection of a transmissible multidrug-resistant influenza A/H3N2 virus in an immunocompromised host publication-title: J. Infect. Dis. contributor: fullname: Taubenberger – volume: 382 start-page: 2302 year: 2020 end-page: 2315 ident: bb0260 article-title: Spread of SARS-CoV-2 in the Icelandic population publication-title: N. Engl. J. Med. contributor: fullname: Stefansson – volume: 53 start-page: 724 year: 2020 end-page: 732 ident: bb0385 article-title: A single immunization with nucleoside-modified mRNA vaccines elicits strong cellular and humoral immune responses against SARS-CoV-2 in mice publication-title: Immunity contributor: fullname: Pardi – volume: 2 year: 2021 ident: bb0495 article-title: Isolating SARS-CoV-2 strains from countries in the same meridian: genome evolutionary analysis publication-title: JMIR Bioinform. Biotech. contributor: fullname: Liu – year: 2021 ident: bb0665 article-title: Prospective mapping of viral mutations that escape antibodies used to treat COVID-19 publication-title: Science. contributor: fullname: Bloom – volume: 383 start-page: 2291 year: 2020 end-page: 2293 ident: bb0090 article-title: Persistence and evolution of SARS-CoV-2 in an immunocompromised host publication-title: N. Engl. J. Med. contributor: fullname: Li – volume: 65 start-page: 569 year: 2020 end-page: 575 ident: bb0350 article-title: Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2 publication-title: J. Hum. Genet. contributor: fullname: Nakamura – volume: 7 start-page: 200636 year: 2020 ident: bb0330 article-title: Presence of mismatches between diagnostic PCR assays and coronavirus SARS-CoV-2 genome publication-title: R. Soc. Open Sci. contributor: fullname: Cheung – volume: 27 start-page: 612 year: 2021 end-page: 615 ident: bb0205 article-title: Early transmission dynamics, spread, and genomic characterization of SARS-CoV-2 in Panama publication-title: Emerg. Infect. Dis. contributor: fullname: Gorgas COVID19 team and Panama COVID19 Laboratory Network – year: 2020 ident: bb0715 article-title: Patterns of within-host genetic diversity in SARS-CoV-2 publication-title: bioRxiv contributor: fullname: Wellcome Sanger Institute COVID-19 Surveillance Team – volume: 12 year: 2020 ident: bb0140 article-title: Genomic epidemiology of the first wave of SARS-CoV-2 in Italy publication-title: Viruses contributor: fullname: Lorusso – volume: 371 start-page: 329 year: 2021 end-page: 330 ident: bb0380 article-title: New mutations raise specter of “immune escape.” publication-title: Science contributor: fullname: Kupferschmidt – volume: 383 start-page: 2603 year: 2020 end-page: 2615 ident: bb0560 article-title: Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine publication-title: N. Engl. J. Med. contributor: fullname: C4591001 Clinical Trial Group – year: 2021 ident: bb0170 article-title: Genomic characterisation of an emergent SARS-CoV-2 lineage in Manaus: preliminary findings SARS-CoV-2 coronavirus contributor: fullname: CADDE Genomic Network – volume: 371 year: 2021 ident: bb0420 article-title: Phylogenetic analysis of SARS-CoV-2 in Boston highlights the impact of superspreading events publication-title: Science contributor: fullname: MacInnis – volume: 371 start-page: 172 year: 2021 end-page: 177 ident: bb0550 article-title: Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans publication-title: Science contributor: fullname: Koopmans – volume: 182 start-page: 812 year: 2020 end-page: 827 ident: bb0360 article-title: Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus publication-title: Cell contributor: fullname: Montefiori – volume: 10 year: 2020 ident: bb0670 article-title: Molecular epidemiology analysis of SARS-CoV-2 strains circulating in Romania during the first months of the pandemic publication-title: Life contributor: fullname: Otelea – year: 2021 ident: bb0185 article-title: ChAdOx1 nCoV-19 (AZD1222) protects hamsters against SARS-CoV-2 B.1.351 and B.1.1.7 disease publication-title: bioRxiv contributor: fullname: Munster – year: 2021 ident: bb0480 article-title: Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B.1.351 variant publication-title: N. Engl. J. Med. contributor: fullname: NGS-SA Group Wits–VIDA COVID Group – start-page: 25 year: 2020 ident: bb0030 article-title: Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 publication-title: Euro. Surveill. contributor: fullname: WHO European Region sequencing laboratories and GISAID EpiCoV group – volume: 584 start-page: 430 year: 2020 end-page: 436 ident: bb0805 article-title: Factors associated with COVID-19-related death using OpenSAFELY publication-title: Nature contributor: fullname: Goldacre – year: 2020 ident: bb0275 article-title: Emergence and spread of a SARS-CoV-2 variant through Europe in the summer of 2020 publication-title: medRxiv contributor: fullname: Neher – volume: 6 year: 2020 ident: bb0470 article-title: No evidence for distinct types in the evolution of SARS-CoV-2 publication-title: Virus Evol. contributor: fullname: Robertson – volume: 12 year: 2020 ident: bb0020 article-title: Preliminary identification of potential vaccine targets for the COVID-19 Coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies publication-title: Viruses contributor: fullname: McKay – volume: 369 start-page: 1603 year: 2020 end-page: 1607 ident: bb0255 article-title: Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy publication-title: Science contributor: fullname: Zhou – volume: 11 start-page: 615280 year: 2020 ident: bb0585 article-title: Evolutionary dynamics and dissemination pattern of the SARS-CoV-2 lineage B.1.1.33 during the early pandemic phase in Brazil publication-title: Front. Microbiol. contributor: fullname: Siqueira – volume: 367 start-page: 1814 year: 2012 end-page: 1820 ident: bb0845 article-title: Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia publication-title: N. Engl. J. Med. contributor: fullname: Fouchier – year: 2021 ident: bb0570 article-title: Pango Lineage Nomenclature: provisional rules for naming recombinant lineages contributor: fullname: Pybus – year: 2021 ident: bb0590 article-title: Spike E484K mutation in the first SARS-CoV-2 reinfection case confirmed in Brazil contributor: fullname: do Carmo Debur, M., Naveca, F.G., Almeida, W., Livorati, M., Bello, G., Siqueira, M.M. – year: 2020 ident: bb0770 article-title: Lineage-specific growth of SARS-CoV-2 B.1.1.7 during the English national lockdown contributor: fullname: The COVID-19 Genomics UK (COG-UK) consortium – year: 2020 ident: bb0325 article-title: Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation publication-title: medRxiv contributor: fullname: Gupta – volume: 225 start-page: 152008 year: 2020 ident: bb0755 article-title: Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies publication-title: Immunobiology contributor: fullname: Kishore – volume: 10 start-page: 575613 year: 2020 ident: bb0025 article-title: Within-host diversity of SARS-CoV-2 in COVID-19 patients with variable disease severities publication-title: Front. Cell. Infect. Microbiol. contributor: fullname: Yassine – year: 2020 ident: bb0365 article-title: A preliminary selection analysis of the South African V501.V2 SARS-CoV-2 clade contributor: fullname: Martin – volume: 583 start-page: 286 year: 2020 end-page: 289 ident: bb0830 article-title: Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins publication-title: Nature contributor: fullname: Shen – volume: 589 start-page: 337 year: 2021 end-page: 338 ident: bb0110 article-title: Alarming COVID variants show vital role of genomic surveillance publication-title: Nature contributor: fullname: Cyranoski – volume: 181 start-page: 1489 year: 2020 end-page: 1501 ident: bb0240 article-title: Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals publication-title: Cell contributor: fullname: Sette – volume: 397 start-page: 445 year: 2021 ident: bb0695 article-title: Genomic sequencing in pandemics publication-title: Lancet contributor: fullname: The Lancet – volume: 5 start-page: 562 year: 2020 end-page: 569 ident: bb0425 article-title: Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses publication-title: Nat. Microbiol. contributor: fullname: Munster – volume: 5 start-page: 1408 year: 2020 end-page: 1417 ident: bb0055 article-title: Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic publication-title: Nat. Microbiol. contributor: fullname: Robertson – year: 2020 ident: bb0270 article-title: Two mutations in the SARS-CoV-2 spike protein and RNA polymerase complex are associated with COVID-19 mortality risk publication-title: Cold Spring Harbor Laboratory. contributor: fullname: Lange – volume: 84 start-page: 104384 year: 2020 ident: bb0645 article-title: SARS-CoV-2 and COVID-19: A genetic, epidemiological, and evolutionary perspective publication-title: Infect. Genet. Evol. contributor: fullname: Editors of Infection, Genetics and Evolution – volume: 6 year: 2010 ident: bb0165 article-title: Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing publication-title: PLoS Pathog. contributor: fullname: Denison – year: 2021 ident: bb0625 article-title: Adaptive immunity to SARS-CoV-2 and COVID-19 publication-title: Cell. contributor: fullname: Crotty – year: 2020 ident: bb0640 article-title: SARS-CoV-2 genomic and quasispecies analyses in cancer patients reveal relaxed intrahost virus evolution publication-title: bioRxiv contributor: fullname: Soares – volume: 370 start-page: 564 year: 2020 end-page: 570 ident: bb0810 article-title: The emergence of SARS-CoV-2 in Europe and North America publication-title: Science contributor: fullname: Lemey – year: 2021 ident: bb0175 article-title: Genomics and epidemiology of a novel SARS-CoV-2 lineage in Manaus, Brazil publication-title: medRxiv. contributor: fullname: Sabino – volume: 383 start-page: 2439 year: 2020 end-page: 2450 ident: bb0785 article-title: Safety and immunogenicity of two RNA-based covid-19 vaccine candidates publication-title: N. Engl. J. Med. contributor: fullname: Gruber – year: 2021 ident: bb0335 article-title: S-variant SARS-CoV-2 lineage B1.1.7 is associated with significantly higher viral loads in samples tested by ThermoFisher TaqPath RT-qPCR publication-title: J. Infect. Dis. contributor: fullname: McNally – volume: 88 start-page: 104684 year: 2020 ident: bb0010 article-title: Two prolonged viremic SARS-CoV-2 infections with conserved viral genome for two months publication-title: Infect. Genet. Evol. contributor: fullname: Bertollini – volume: 12 year: 2020 ident: bb0565 article-title: Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2 publication-title: Sci. Transl. Med. contributor: fullname: Bergthaler – volume: 26 start-page: 450 year: 2020 end-page: 452 ident: bb0035 article-title: The proximal origin of SARS-CoV-2 publication-title: Nat. Med. contributor: fullname: Garry – volume: 184 start-page: 64 year: 2021 end-page: 75 ident: bb0780 article-title: Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity publication-title: Cell contributor: fullname: Connor – year: 2021 ident: bb0290 article-title: Recombinant SARS-CoV-2 genomes involving lineage B.1.1.7 in the UK contributor: fullname: The COVID-19 Genomics UK (COG-UK) consortium – volume: 9 year: 2020 ident: bb0005 article-title: Evidence for SARS-CoV-2 Infection of Animal Hosts publication-title: Pathogens contributor: fullname: Abdelwhab – volume: 25 year: 2020 ident: bb0860 article-title: SARS-CoV-2 samples may escape detection because of a single point mutation in the N gene publication-title: Euro Surveill. contributor: fullname: Ensser – year: 2021 ident: bb0490 article-title: The emergence and ongoing convergent evolution of the N501Y lineages coincides with a major global shift in the SARS-CoV-2 selective landscape publication-title: medRxiv contributor: fullname: Pond – volume: 396 start-page: 603 year: 2020 end-page: 611 ident: bb0840 article-title: Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study publication-title: Lancet. contributor: fullname: Ng – year: 2021 ident: bb0720 article-title: Temporal dynamics of SARS-CoV-2 mutation accumulation within and across infected hosts publication-title: bioRxiv contributor: fullname: Lauring – year: 2020 ident: bb0400 article-title: Identification of a novel SARS-CoV-2 Spike 69-70 deletion lineage circulating in the United States contributor: fullname: Worobey – volume: 586 start-page: 589 year: 2020 end-page: 593 ident: bb0530 article-title: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults publication-title: Nature contributor: fullname: Jansen – year: 2021 ident: bb0690 article-title: Sixteen novel lineages of SARS-CoV-2 in South Africa publication-title: Nat. Med. contributor: fullname: de Oliveira – year: 2021 ident: bb0065 article-title: Tracking SARS-CoV-2 VOC 202012/01 (lineage B.1.1.7) dissemination in Portugal: insights from nationwide RT-PCR Spike gene drop out data contributor: fullname: Gomes – volume: 6 year: 2020 ident: bb0155 article-title: Temporal signal and the phylodynamic threshold of SARS-CoV-2 publication-title: Virus Evol. contributor: fullname: Baele – volume: 25 start-page: 35 year: 2017 end-page: 48 ident: bb0200 article-title: Molecular evolution of human coronavirus genomes publication-title: Trends Microbiol. contributor: fullname: Sironi – volume: 34 start-page: 4121 year: 2018 end-page: 4123 ident: bb0265 article-title: Nextstrain: real-time tracking of pathogen evolution publication-title: Bioinformatics contributor: fullname: Neher – volume: 54 start-page: 156 year: 2002 end-page: 165 ident: bb0295 article-title: Rates of molecular evolution in RNA viruses: a quantitative phylogenetic analysis publication-title: J. Mol. Evol. contributor: fullname: Holmes – year: 2021 ident: bb0070 article-title: Infection sustained by lineage B.1.1.7 of SARS-CoV-2 is characterised by longer persistence and higher viral RNA loads in nasopharyngeal swabs publication-title: Int. J. Infect. Dis. contributor: fullname: Lorusso – volume: 5 start-page: 1598 year: 2020 end-page: 1607 ident: bb0620 article-title: Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans publication-title: Nat. Microbiol. contributor: fullname: Doores – year: 2021 ident: bb0680 article-title: Negligible impact of SARS-CoV-2 variants on CD4 + and CD8 + T cell reactivity in COVID-19 exposed donors and vaccinees publication-title: bioRxivorg contributor: fullname: Sette – volume: 26 year: 2021 ident: bb0060 article-title: Tracking SARS-CoV-2 lineage B.1.1.7 dissemination: insights from nationwide spike gene target failure (SGTF) and spike gene late detection (SGTL) data, Portugal, week 49 2020 to week 3 2021 publication-title: Euro. Surveill. contributor: fullname: Gomes – volume: 16 year: 2021 ident: bb0355 article-title: Molecular characterization and the mutation pattern of SARS-CoV-2 during first and second wave outbreaks in Hiroshima, Japan publication-title: PLoS One contributor: fullname: Tanaka – volume: 29 start-page: 463 year: 2021 end-page: 476 ident: bb0230 article-title: Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies publication-title: Cell Host Microbe contributor: fullname: Bloom – volume: 26 start-page: 1405 year: 2020 end-page: 1410 ident: bb0545 article-title: Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the Netherlands publication-title: Nat. Med. contributor: fullname: Dutch-Covid-19 response team – year: 2020 ident: bb0555 article-title: Spike mutation D614G alters SARS-CoV-2 fitness publication-title: Nature. contributor: fullname: Shi – volume: 183 start-page: 996 year: 2020 end-page: 1012 ident: bb0605 article-title: Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity publication-title: Cell contributor: fullname: Crotty – year: 2021 ident: bb0280 article-title: Emergence in late 2020 of multiple lineages of SARS-CoV-2 Spike protein variants affecting amino acid position 677 publication-title: medRxiv contributor: fullname: Kamil – volume: 11 start-page: 1748 year: 2020 ident: bb0105 article-title: Remodeling of the immune response with aging: immunosenescence and its potential impact on COVID-19 immune response publication-title: Front. Immunol. contributor: fullname: Riella – volume: 371 start-page: 1152 year: 2021 end-page: 1153 ident: bb0525 article-title: Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera publication-title: Science contributor: fullname: Şahin – year: 2021 ident: bb0345 article-title: Densely sampled viral trajectories suggest longer duration of acute infection with B.1.1.7 variant relative to non-B.1.1.7 SARS-CoV-2 publication-title: bioRxiv contributor: fullname: Grad – volume: 29 start-page: 456 year: 1999 end-page: 458 ident: bb0510 article-title: Antigenic drift of influenza A (H3N2) virus in a persistently infected immunocompromised host is similar to that occurring in the community publication-title: Clin. Infect. Dis. contributor: fullname: Hampson – volume: 7 start-page: 133 year: 2007 end-page: 144 ident: bb0745 article-title: Virus species and virus identification: past and current controversies publication-title: Infect. Genet. Evol. contributor: fullname: Van Regenmortel – year: 2021 ident: bb0750 article-title: Recombinant SARS-CoV-2 genomes are currently circulating at low levels publication-title: bioRxiv contributor: fullname: Koelle – volume: 89 start-page: 5756 year: 2015 end-page: 5759 ident: bb0310 article-title: What is the reservoir of emergent human norovirus strains? publication-title: J. Virol. contributor: fullname: Baric – volume: 5 start-page: 536 year: 2020 end-page: 544 ident: bb0095 article-title: The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 publication-title: Nat. Microbiol. contributor: fullname: Coronaviridae Study Group of the International Committee on Taxonomy of Viruses – volume: 158 start-page: 301 year: 2013 end-page: 311 ident: bb0375 article-title: Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae publication-title: Arch. Virol. contributor: fullname: Nichol – volume: 11 start-page: 5986 year: 2020 ident: bb0735 article-title: No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2 publication-title: Nat. Commun. contributor: fullname: Balloux – volume: 10 start-page: 3054 year: 2019 ident: bb0040 article-title: Molecular evolution of the fusion protein gene in human respirovirus 3 publication-title: Front. Microbiol. contributor: fullname: Takizawa – volume: 20 start-page: 1160 year: 2019 end-page: 1166 ident: bb0320 article-title: MAFFT online service: multiple sequence alignment, interactive sequence choice and visualization publication-title: Brief. Bioinform. contributor: fullname: Yamada – volume: 17 year: 2021 ident: bb0235 article-title: The coronavirus proofreading exoribonuclease mediates extensive viral recombination publication-title: PLoS Pathog. contributor: fullname: Denison – volume: 11 year: 2020 ident: bb0390 article-title: An early pandemic analysis of SARS-CoV-2 population structure and dynamics in Arizona publication-title: MBio contributor: fullname: Keim – volume: 30 start-page: 3896 year: 2020 ident: bb0850 article-title: A novel bat coronavirus closely related to SARS-CoV-2 contains natural insertions at the S1/S2 cleavage site of the spike protein publication-title: Curr. Biol. contributor: fullname: Shi – year: 2020 ident: bb0675 article-title: On the origin and continuing evolution of SARS-CoV-2 publication-title: Natl. Sci. Rev. contributor: fullname: Lu – volume: 369 start-page: 1255 year: 2020 end-page: 1260 ident: bb0075 article-title: Evolution and epidemic spread of SARS-CoV-2 in Brazil publication-title: Science contributor: fullname: Faria – volume: 9 start-page: 2571 year: 2020 end-page: 2577 ident: bb0445 article-title: Prolonged shedding of severe acute respiratory syndrome coronavirus 2 in patients with COVID-19 publication-title: Emerg. Microbes Infect. contributor: fullname: Zhou – year: 2021 ident: bb0050 article-title: Emergence of Y453F and Δ69-70HV mutations in a lymphoma patient with long-term COVID-19 contributor: fullname: Lioznov – volume: 59 start-page: 1470 year: 2013 end-page: 1480 ident: bb0415 article-title: Single-nucleotide polymorphisms and other mismatches reduce performance of quantitative PCR assays publication-title: Clin. Chem. contributor: fullname: Vandesompele – year: 2021 ident: bb0405 article-title: Phylogenetic evidence that B.1.1.7 has been circulating in the United States since early- to mid-November contributor: fullname: Worobey – volume: 184 start-page: 1171 year: 2021 end-page: 1187 ident: bb0700 article-title: Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity publication-title: Cell contributor: fullname: Snell – year: 2021 ident: bb0800 article-title: SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma publication-title: bioRxiv contributor: fullname: Moore – volume: 26 start-page: 1714 year: 2020 end-page: 1719 ident: bb0015 article-title: Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong publication-title: Nat. Med. contributor: fullname: Cowling – year: 2021 ident: bb0135 article-title: Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation publication-title: bioRxiv contributor: fullname: Chiu – volume: 27 start-page: 1522 year: 2021 end-page: 1524 ident: bb0760 article-title: Genomic evidence of a SARS-CoV-2 reinfection case with E484K spike mutation in Brazil publication-title: Emerging Infectious Diseases contributor: fullname: Solano de Freitas Souza – volume: 9 start-page: 221 year: 2020 end-page: 236 ident: bb0080 article-title: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan publication-title: Emerg. Microbes Infect. contributor: fullname: Yuen – year: 2021 ident: bb0610 article-title: Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence publication-title: Lancet. contributor: fullname: Faria – year: 2021 ident: bb0535 article-title: SARS-CoV-2 reinfection by the new Variant of Concern (VOC) P.1 in Amazonas, Brazil contributor: fullname: Resende – volume: 372 year: 2021 ident: bb0120 article-title: Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England publication-title: Science contributor: fullname: Edmunds – volume: 9 year: 2020 ident: bb0370 article-title: Emergence of drift variants that may affect COVID-19 vaccine development and antibody treatment publication-title: Pathogens contributor: fullname: Parida – volume: 579 start-page: 270 year: 2020 end-page: 273 ident: bb0855 article-title: A pneumonia outbreak associated with a new coronavirus of probable bat origin publication-title: Nature contributor: fullname: Shi – volume: 85 start-page: 104502 year: 2020 ident: bb0340 article-title: From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses publication-title: Infect. Genet. Evol. contributor: fullname: Kang – volume: 395 year: 2020 ident: bb0450 article-title: Secondary attack rate and superspreading events for SARS-CoV-2 publication-title: Lancet contributor: fullname: Kucharski – year: 2020 ident: bb0580 article-title: Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations contributor: fullname: COVID-19 Genomics Consortium UK (CoG-UK). – year: 2021 ident: bb0215 article-title: Spike protein mutations in novel SARS-CoV-2 ‘variants of concern’ commonly occur in or near indels contributor: fullname: Holmes – year: 2020 ident: bb0395 article-title: Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins publication-title: Nature. contributor: fullname: Cao – volume: 11 start-page: 4235 year: 2020 ident: bb0410 article-title: Origin and cross-species transmission of bat coronaviruses in China publication-title: Nat. Commun. contributor: fullname: Daszak – volume: 182 start-page: 1284 year: 2020 end-page: 1294 ident: bb0440 article-title: The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity publication-title: Cell contributor: fullname: Wang – year: 2021 ident: bb0790 article-title: mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants publication-title: bioRxiv contributor: fullname: Nussenzweig – year: 2020 ident: bb0775 article-title: Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data contributor: fullname: Ferguson – volume: 183 start-page: 1901 year: 2020 end-page: 1912 ident: bb0045 article-title: Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer publication-title: Cell contributor: fullname: Munster – volume: 348 start-page: 1967 year: 2003 end-page: 1976 ident: bb0145 article-title: Identification of a novel coronavirus in patients with severe acute respiratory syndrome publication-title: N. Engl. J. Med. contributor: fullname: Doerr – volume: 396 start-page: 467 year: 2020 end-page: 478 ident: bb0195 article-title: Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial publication-title: Lancet contributor: fullname: Oxford COVID Vaccine Trial Group – volume: 5 start-page: 1403 year: 2020 end-page: 1407 ident: bb0575 article-title: A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology publication-title: Nat. Microbiol. contributor: fullname: Pybus – volume: 19 year: 2021 ident: bb0475 article-title: Natural selection in the evolution of SARS-CoV-2 in bats created a generalist virus and highly capable human pathogen publication-title: PLoS Biol. contributor: fullname: Robertson – year: 2021 ident: bb0825 article-title: mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants publication-title: bioRxiv contributor: fullname: Edwards – volume: 79 start-page: 1595 year: 2005 end-page: 1604 ident: bb0765 article-title: Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event publication-title: J. Virol. contributor: fullname: Van Ranst – start-page: 26 year: 2021 ident: bb0430 article-title: Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020 publication-title: Euro. Surveill. contributor: fullname: Wu – volume: 6 year: 2015 ident: bb0595 article-title: Intrahost dynamics of antiviral resistance in influenza A virus reflect complex patterns of segment linkage, reassortment, and natural selection publication-title: MBio contributor: fullname: Ghedin – volume: 11 start-page: 579250 year: 2020 ident: bb0190 article-title: Progress and pitfalls in the quest for effective SARS-CoV-2 (COVID-19) vaccines publication-title: Front. Immunol. contributor: fullname: Wen – volume: 586 start-page: 594 year: 2020 end-page: 599 ident: bb0615 article-title: COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses publication-title: Nature. contributor: fullname: Türeci – volume: 583 start-page: 286 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0830 article-title: Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins publication-title: Nature doi: 10.1038/s41586-020-2313-x contributor: fullname: Xiao – volume: 16 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0705 article-title: New pathways of mutational change in SARS-CoV-2 proteomes involve regions of intrinsic disorder important for virus replication and release publication-title: Evol. Bioinform. Online doi: 10.1177/1176934320965149 contributor: fullname: Tomaszewski – volume: 369 start-page: 1255 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0075 article-title: Evolution and epidemic spread of SARS-CoV-2 in Brazil publication-title: Science doi: 10.1126/science.abd2161 contributor: fullname: Candido – year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0130 article-title: A phylodynamic workflow to rapidly gain insights into the dispersal history and dynamics of SARS-CoV-2 lineages publication-title: Mol. Biol. Evol. contributor: fullname: Dellicour – volume: 372 issue: 6538 year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0120 article-title: Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England publication-title: Science doi: 10.1126/science.abg3055 contributor: fullname: Davies – volume: 20 start-page: 615 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0300 article-title: Immunological considerations for COVID-19 vaccine strategies publication-title: Nat. Rev. Immunol. doi: 10.1038/s41577-020-00434-6 contributor: fullname: Jeyanathan – volume: 9 year: 2013 ident: 10.1016/j.meegid.2021.104869_bb0650 article-title: Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1003565 contributor: fullname: Smith – year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0150 article-title: Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK publication-title: Science doi: 10.1126/science.abf2946 contributor: fullname: du Plessis – volume: 10 start-page: 3054 year: 2019 ident: 10.1016/j.meegid.2021.104869_bb0040 article-title: Molecular evolution of the fusion protein gene in human respirovirus 3 publication-title: Front. Microbiol. doi: 10.3389/fmicb.2019.03054 contributor: fullname: Aso – year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0505 article-title: N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2 publication-title: Cell. doi: 10.1016/j.cell.2021.03.028 contributor: fullname: McCallum – ident: 10.1016/j.meegid.2021.104869_bb0050 contributor: fullname: Bazykin – volume: 65 start-page: 569 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0350 article-title: Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2 publication-title: J. Hum. Genet. doi: 10.1038/s10038-020-0771-5 contributor: fullname: Kiyotani – volume: 10 start-page: 575613 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0025 article-title: Within-host diversity of SARS-CoV-2 in COVID-19 patients with variable disease severities publication-title: Front. Cell. Infect. Microbiol. doi: 10.3389/fcimb.2020.575613 contributor: fullname: Al Khatib – volume: 9 start-page: 2571 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0445 article-title: Prolonged shedding of severe acute respiratory syndrome coronavirus 2 in patients with COVID-19 publication-title: Emerg. Microbes Infect. doi: 10.1080/22221751.2020.1852058 contributor: fullname: Li – volume: 7 start-page: 133 year: 2007 ident: 10.1016/j.meegid.2021.104869_bb0745 article-title: Virus species and virus identification: past and current controversies publication-title: Infect. Genet. Evol. doi: 10.1016/j.meegid.2006.04.002 contributor: fullname: Van Regenmortel – volume: 27 start-page: 1522 issue: 5 year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0760 article-title: Genomic evidence of a SARS-CoV-2 reinfection case with E484K spike mutation in Brazil publication-title: Emerging Infectious Diseases doi: 10.3201/eid2705.210191 contributor: fullname: Vasques Nonaka – year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0275 article-title: Emergence and spread of a SARS-CoV-2 variant through Europe in the summer of 2020 publication-title: medRxiv contributor: fullname: Hodcroft – volume: 6 start-page: 112 year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0115 article-title: Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland publication-title: Nat. Microbiol. doi: 10.1038/s41564-020-00838-z contributor: fullname: da Silva Filipe – volume: 53 start-page: 724 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0385 article-title: A single immunization with nucleoside-modified mRNA vaccines elicits strong cellular and humoral immune responses against SARS-CoV-2 in mice publication-title: Immunity doi: 10.1016/j.immuni.2020.07.019 contributor: fullname: Laczkó – volume: 27 start-page: 73 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0085 article-title: The origin and underlying driving forces of the SARS-CoV-2 outbreak publication-title: J. Biomed. Sci. doi: 10.1186/s12929-020-00665-8 contributor: fullname: Chaw – volume: 40 start-page: 37 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0635 article-title: The continued epidemic threat of SARS-CoV-2 and implications for the future of global public health publication-title: Curr. Opin. Virol. doi: 10.1016/j.coviro.2020.05.010 contributor: fullname: Sheahan – ident: 10.1016/j.meegid.2021.104869_bb0365 contributor: fullname: Kosakovsky Pond – volume: 6 year: 2010 ident: 10.1016/j.meegid.2021.104869_bb0165 article-title: Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1000896 contributor: fullname: Eckerle – volume: 26 start-page: 845 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0460 article-title: Antibody responses to SARS-CoV-2 in patients with COVID-19 publication-title: Nat. Med. doi: 10.1038/s41591-020-0897-1 contributor: fullname: Long – volume: 11 start-page: 579250 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0190 article-title: Progress and pitfalls in the quest for effective SARS-CoV-2 (COVID-19) vaccines publication-title: Front. Immunol. doi: 10.3389/fimmu.2020.579250 contributor: fullname: Flanagan – year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0270 article-title: Two mutations in the SARS-CoV-2 spike protein and RNA polymerase complex are associated with COVID-19 mortality risk publication-title: Cold Spring Harbor Laboratory. contributor: fullname: Hahn – year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0395 article-title: Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins publication-title: Nature. doi: 10.1038/s41586-020-2169-0 contributor: fullname: Lam – volume: 30 start-page: 1312 year: 2014 ident: 10.1016/j.meegid.2021.104869_bb0660 article-title: RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies publication-title: Bioinformatics doi: 10.1093/bioinformatics/btu033 contributor: fullname: Stamatakis – ident: 10.1016/j.meegid.2021.104869_bb0405 contributor: fullname: Larsen – year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0685 article-title: Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa publication-title: medRxiv contributor: fullname: Tegally – volume: 589 start-page: 337 year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0110 article-title: Alarming COVID variants show vital role of genomic surveillance publication-title: Nature doi: 10.1038/d41586-021-00065-4 contributor: fullname: Cyranoski – volume: 84 start-page: 104384 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0645 article-title: SARS-CoV-2 and COVID-19: A genetic, epidemiological, and evolutionary perspective publication-title: Infect. Genet. Evol. doi: 10.1016/j.meegid.2020.104384 contributor: fullname: Sironi – year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0680 article-title: Negligible impact of SARS-CoV-2 variants on CD4 + and CD8 + T cell reactivity in COVID-19 exposed donors and vaccinees publication-title: bioRxivorg contributor: fullname: Tarke – volume: 27 start-page: 612 year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0205 article-title: Early transmission dynamics, spread, and genomic characterization of SARS-CoV-2 in Panama publication-title: Emerg. Infect. Dis. doi: 10.3201/eid2702.203767 contributor: fullname: Franco – volume: 371 year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0420 article-title: Phylogenetic analysis of SARS-CoV-2 in Boston highlights the impact of superspreading events publication-title: Science doi: 10.1126/science.abe3261 contributor: fullname: Lemieux – volume: 383 start-page: 2603 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0560 article-title: Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2034577 contributor: fullname: Polack – volume: 5 start-page: 1598 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0620 article-title: Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans publication-title: Nat. Microbiol. doi: 10.1038/s41564-020-00813-8 contributor: fullname: Seow – volume: 584 start-page: 430 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0805 article-title: Factors associated with COVID-19-related death using OpenSAFELY publication-title: Nature doi: 10.1038/s41586-020-2521-4 contributor: fullname: Williamson – volume: 8 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0540 article-title: SARS-CoV-2 consensus-sequence and matching overlapping peptides design for COVID19 immune studies and vaccine development publication-title: Vaccines (Basel) contributor: fullname: Olvera – volume: 5 start-page: 529 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0250 article-title: We shouldn’t worry when a virus mutates during disease outbreaks publication-title: Nat. Microbiol. doi: 10.1038/s41564-020-0690-4 contributor: fullname: Grubaugh – volume: 369 start-page: 1603 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0255 article-title: Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy publication-title: Science doi: 10.1126/science.abc4730 contributor: fullname: Gu – volume: 12 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0020 article-title: Preliminary identification of potential vaccine targets for the COVID-19 Coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies publication-title: Viruses doi: 10.3390/v12030254 contributor: fullname: Ahmed – volume: 182 start-page: 1284 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0440 article-title: The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity publication-title: Cell doi: 10.1016/j.cell.2020.07.012 contributor: fullname: Li – volume: 182 start-page: 812 issue: 4 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0245 article-title: Making sense of mutation: what D614G means for the COVID-19 pandemic remains unclear publication-title: Cell. doi: 10.1016/j.cell.2020.06.040 contributor: fullname: Grubaugh – volume: 81 start-page: 12135 year: 2007 ident: 10.1016/j.meegid.2021.104869_bb0160 article-title: High fidelity of murine hepatitis virus replication is decreased in nsp14 exoribonuclease mutants publication-title: J. Virol. doi: 10.1128/JVI.01296-07 contributor: fullname: Eckerle – volume: 6 year: 2015 ident: 10.1016/j.meegid.2021.104869_bb0595 article-title: Intrahost dynamics of antiviral resistance in influenza A virus reflect complex patterns of segment linkage, reassortment, and natural selection publication-title: MBio doi: 10.1128/mBio.02464-14 contributor: fullname: Rogers – volume: 367 start-page: 1814 year: 2012 ident: 10.1016/j.meegid.2021.104869_bb0845 article-title: Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1211721 contributor: fullname: Zaki – volume: 25 start-page: 35 year: 2017 ident: 10.1016/j.meegid.2021.104869_bb0200 article-title: Molecular evolution of human coronavirus genomes publication-title: Trends Microbiol. doi: 10.1016/j.tim.2016.09.001 contributor: fullname: Forni – volume: 158 start-page: 301 year: 2013 ident: 10.1016/j.meegid.2021.104869_bb0375 article-title: Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae publication-title: Arch. Virol. doi: 10.1007/s00705-012-1454-0 contributor: fullname: Kuhn – year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0825 article-title: mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants publication-title: bioRxiv contributor: fullname: Wu – volume: 17 start-page: 181 year: 2019 ident: 10.1016/j.meegid.2021.104869_bb0100 article-title: Origin and evolution of pathogenic coronaviruses publication-title: Nat. Rev. Microbiol. doi: 10.1038/s41579-018-0118-9 contributor: fullname: Cui – year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0835 article-title: Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera publication-title: bioRxiv contributor: fullname: Xie – year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0280 article-title: Emergence in late 2020 of multiple lineages of SARS-CoV-2 Spike protein variants affecting amino acid position 677 publication-title: medRxiv contributor: fullname: Hodcroft – volume: 11 start-page: 5986 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0735 article-title: No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2 publication-title: Nat. Commun. doi: 10.1038/s41467-020-19818-2 contributor: fullname: van Dorp – volume: 7 start-page: 200636 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0330 article-title: Presence of mismatches between diagnostic PCR assays and coronavirus SARS-CoV-2 genome publication-title: R. Soc. Open Sci. doi: 10.1098/rsos.200636 contributor: fullname: Khan – volume: 382 start-page: 1199 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0435 article-title: Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2001316 contributor: fullname: Li – volume: 586 start-page: 594 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0615 article-title: COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses publication-title: Nature. doi: 10.1038/s41586-020-2814-7 contributor: fullname: Sahin – year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0490 article-title: The emergence and ongoing convergent evolution of the N501Y lineages coincides with a major global shift in the SARS-CoV-2 selective landscape publication-title: medRxiv contributor: fullname: Martin – ident: 10.1016/j.meegid.2021.104869_bb0170 contributor: fullname: Faria – year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0325 article-title: Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation publication-title: medRxiv contributor: fullname: Kemp – volume: 17 year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0235 article-title: The coronavirus proofreading exoribonuclease mediates extensive viral recombination publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1009226 contributor: fullname: Gribble – volume: 383 start-page: 2291 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0090 article-title: Persistence and evolution of SARS-CoV-2 in an immunocompromised host publication-title: N. Engl. J. Med. doi: 10.1056/NEJMc2031364 contributor: fullname: Choi – year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0655 article-title: A main event and multiple introductions of SARS-Cov2 initiated the COVID-19 epidemic in Greece publication-title: J. Med. Virol. doi: 10.1002/jmv.26778 contributor: fullname: Spanakis – volume: 82 start-page: 36 year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0485 article-title: SARS-CoV-2 (COVID-19) superspreader events publication-title: J. Infect. doi: 10.1016/j.jinf.2020.11.021 contributor: fullname: Majra – year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0690 article-title: Sixteen novel lineages of SARS-CoV-2 in South Africa publication-title: Nat. Med. doi: 10.1038/s41591-021-01255-3 contributor: fullname: Tegally – year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0740 article-title: Recurrent mutations in SARS-CoV-2 genomes isolated from mink point to rapid host-adaptation publication-title: Cold Spring Harbor Laboratory. contributor: fullname: van Dorp – volume: 371 start-page: 172 year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0550 article-title: Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans publication-title: Science doi: 10.1126/science.abe5901 contributor: fullname: Oude Munnink – volume: 41 start-page: 109 year: 2018 ident: 10.1016/j.meegid.2021.104869_bb0600 article-title: In silico prediction of T- and B-cell epitopes in PmpD: First step towards to the design of a Chlamydia trachomatis vaccine publication-title: Biomed. J. doi: 10.1016/j.bj.2018.04.007 contributor: fullname: Russi – volume: 59 start-page: 1470 year: 2013 ident: 10.1016/j.meegid.2021.104869_bb0415 article-title: Single-nucleotide polymorphisms and other mismatches reduce performance of quantitative PCR assays publication-title: Clin. Chem. doi: 10.1373/clinchem.2013.203653 contributor: fullname: Lefever – volume: 145 start-page: 104236 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0305 article-title: Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2 publication-title: Microb. Pathog. doi: 10.1016/j.micpath.2020.104236 contributor: fullname: Kalita – year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0285 article-title: SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies publication-title: Cell doi: 10.1016/j.cell.2021.03.036 contributor: fullname: Hoffmann – volume: 7 year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0795 article-title: The evolutionary history of ACE2 usage within the coronavirus subgenus publication-title: Virus Evol. doi: 10.1093/ve/veab007 contributor: fullname: Wells – volume: 371 start-page: 329 year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0380 article-title: New mutations raise specter of “immune escape.” publication-title: Science doi: 10.1126/science.371.6527.329 contributor: fullname: Kupferschmidt – volume: 586 start-page: 578 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0725 article-title: ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques publication-title: Nature doi: 10.1038/s41586-020-2608-y contributor: fullname: van Doremalen – volume: 397 start-page: 445 year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0695 article-title: Genomic sequencing in pandemics publication-title: Lancet doi: 10.1016/S0140-6736(21)00257-9 contributor: fullname: The Lancet – year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0125 article-title: Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7 publication-title: Nature. doi: 10.1038/s41586-021-03426-1 contributor: fullname: Davies – volume: 367 start-page: 1260 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0815 article-title: Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation publication-title: Science doi: 10.1126/science.abb2507 contributor: fullname: Wrapp – volume: 579 start-page: 270 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0855 article-title: A pneumonia outbreak associated with a new coronavirus of probable bat origin publication-title: Nature doi: 10.1038/s41586-020-2012-7 contributor: fullname: Zhou – volume: 183 start-page: 1901 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0045 article-title: Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer publication-title: Cell doi: 10.1016/j.cell.2020.10.049 contributor: fullname: Avanzato – ident: 10.1016/j.meegid.2021.104869_bb0220 contributor: fullname: Ghafari – volume: 16 year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0355 article-title: Molecular characterization and the mutation pattern of SARS-CoV-2 during first and second wave outbreaks in Hiroshima, Japan publication-title: PLoS One doi: 10.1371/journal.pone.0246383 contributor: fullname: Ko – start-page: 25 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0030 article-title: Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 publication-title: Euro. Surveill. contributor: fullname: Alm – year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0715 article-title: Patterns of within-host genetic diversity in SARS-CoV-2 publication-title: bioRxiv contributor: fullname: Tonkin-Hill – ident: 10.1016/j.meegid.2021.104869_bb0535 contributor: fullname: Naveca – ident: 10.1016/j.meegid.2021.104869_bb0710 contributor: fullname: Tomkins-Tinch – volume: 20 start-page: 1160 year: 2019 ident: 10.1016/j.meegid.2021.104869_bb0320 article-title: MAFFT online service: multiple sequence alignment, interactive sequence choice and visualization publication-title: Brief. Bioinform. doi: 10.1093/bib/bbx108 contributor: fullname: Katoh – volume: 225 start-page: 152008 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0755 article-title: Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies publication-title: Immunobiology doi: 10.1016/j.imbio.2020.152008 contributor: fullname: Varghese – volume: 26 start-page: 1405 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0545 article-title: Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the Netherlands publication-title: Nat. Med. doi: 10.1038/s41591-020-0997-y contributor: fullname: Oude Munnink – volume: 11 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0390 article-title: An early pandemic analysis of SARS-CoV-2 population structure and dynamics in Arizona publication-title: MBio doi: 10.1128/mBio.02107-20 contributor: fullname: Ladner – volume: 11 start-page: 615280 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0585 article-title: Evolutionary dynamics and dissemination pattern of the SARS-CoV-2 lineage B.1.1.33 during the early pandemic phase in Brazil publication-title: Front. Microbiol. doi: 10.3389/fmicb.2020.615280 contributor: fullname: Resende – year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0640 article-title: SARS-CoV-2 genomic and quasispecies analyses in cancer patients reveal relaxed intrahost virus evolution publication-title: bioRxiv contributor: fullname: Siqueira – ident: 10.1016/j.meegid.2021.104869_bb0570 contributor: fullname: Pybus – volume: 5 start-page: 1408 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0055 article-title: Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic publication-title: Nat. Microbiol. doi: 10.1038/s41564-020-0771-4 contributor: fullname: Boni – volume: 85 start-page: 104502 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0340 article-title: From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses publication-title: Infect. Genet. Evol. doi: 10.1016/j.meegid.2020.104502 contributor: fullname: Kirtipal – year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0480 article-title: Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B.1.351 variant publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2102214 contributor: fullname: Madhi – volume: 201 start-page: 1397 year: 2010 ident: 10.1016/j.meegid.2021.104869_bb0515 article-title: Rapid selection of a transmissible multidrug-resistant influenza A/H3N2 virus in an immunocompromised host publication-title: J. Infect. Dis. doi: 10.1086/651610 contributor: fullname: Memoli – year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0665 article-title: Prospective mapping of viral mutations that escape antibodies used to treat COVID-19 publication-title: Science. doi: 10.1126/science.abf9302 contributor: fullname: Starr – ident: 10.1016/j.meegid.2021.104869_bb0215 contributor: fullname: Garry – volume: 26 start-page: 450 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0035 article-title: The proximal origin of SARS-CoV-2 publication-title: Nat. Med. doi: 10.1038/s41591-020-0820-9 contributor: fullname: Andersen – volume: 181 start-page: 1489 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0240 article-title: Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals publication-title: Cell doi: 10.1016/j.cell.2020.05.015 contributor: fullname: Grifoni – volume: 89 start-page: 5756 year: 2015 ident: 10.1016/j.meegid.2021.104869_bb0310 article-title: What is the reservoir of emergent human norovirus strains? publication-title: J. Virol. doi: 10.1128/JVI.03063-14 contributor: fullname: Karst – year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0625 article-title: Adaptive immunity to SARS-CoV-2 and COVID-19 publication-title: Cell. doi: 10.1016/j.cell.2021.01.007 contributor: fullname: Sette – year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0800 article-title: SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma publication-title: bioRxiv contributor: fullname: Wibmer – year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0750 article-title: Recombinant SARS-CoV-2 genomes are currently circulating at low levels publication-title: bioRxiv contributor: fullname: VanInsberghe – volume: 579 start-page: 265 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0820 article-title: A new coronavirus associated with human respiratory disease in China publication-title: Nature doi: 10.1038/s41586-020-2008-3 contributor: fullname: Wu – year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0070 article-title: Infection sustained by lineage B.1.1.7 of SARS-CoV-2 is characterised by longer persistence and higher viral RNA loads in nasopharyngeal swabs publication-title: Int. J. Infect. Dis. doi: 10.1016/j.ijid.2021.03.005 contributor: fullname: Calistri – volume: 370 start-page: 564 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0810 article-title: The emergence of SARS-CoV-2 in Europe and North America publication-title: Science doi: 10.1126/science.abc8169 contributor: fullname: Worobey – volume: 11 start-page: 585354 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0630 article-title: A review of the progress and challenges of developing a vaccine for COVID-19 publication-title: Front. Immunol. doi: 10.3389/fimmu.2020.585354 contributor: fullname: Sharma – ident: 10.1016/j.meegid.2021.104869_bb0400 contributor: fullname: Larsen – volume: 54 start-page: 156 year: 2002 ident: 10.1016/j.meegid.2021.104869_bb0295 article-title: Rates of molecular evolution in RNA viruses: a quantitative phylogenetic analysis publication-title: J. Mol. Evol. doi: 10.1007/s00239-001-0064-3 contributor: fullname: Jenkins – volume: 182 start-page: 812 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0360 article-title: Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus publication-title: Cell doi: 10.1016/j.cell.2020.06.043 contributor: fullname: Korber – ident: 10.1016/j.meegid.2021.104869_bb0520 contributor: fullname: Moreno – year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0720 article-title: Temporal dynamics of SARS-CoV-2 mutation accumulation within and across infected hosts publication-title: bioRxiv contributor: fullname: Valesano – volume: 25 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0860 article-title: SARS-CoV-2 samples may escape detection because of a single point mutation in the N gene publication-title: Euro Surveill. doi: 10.2807/1560-7917.ES.2020.25.39.2001650 contributor: fullname: Ziegler – volume: 6 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0155 article-title: Temporal signal and the phylodynamic threshold of SARS-CoV-2 publication-title: Virus Evol. doi: 10.1093/ve/veaa061 contributor: fullname: Duchene – volume: 34 start-page: 4121 year: 2018 ident: 10.1016/j.meegid.2021.104869_bb0265 article-title: Nextstrain: real-time tracking of pathogen evolution publication-title: Bioinformatics doi: 10.1093/bioinformatics/bty407 contributor: fullname: Hadfield – year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0500 article-title: SARS-CoV-2 immune evasion by variant B.1.427/B.1.429 publication-title: bioRxiv contributor: fullname: McCallum – year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0180 article-title: Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains publication-title: bioRxiv contributor: fullname: Faulkner – volume: 371 start-page: 1152 year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0525 article-title: Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera publication-title: Science doi: 10.1126/science.abg6105 contributor: fullname: Muik – volume: 9 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0370 article-title: Emergence of drift variants that may affect COVID-19 vaccine development and antibody treatment publication-title: Pathogens doi: 10.3390/pathogens9050324 contributor: fullname: Koyama – volume: 6 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0470 article-title: No evidence for distinct types in the evolution of SARS-CoV-2 publication-title: Virus Evol. doi: 10.1093/ve/veaa034 contributor: fullname: MacLean – volume: 29 start-page: 456 year: 1999 ident: 10.1016/j.meegid.2021.104869_bb0510 article-title: Antigenic drift of influenza A (H3N2) virus in a persistently infected immunocompromised host is similar to that occurring in the community publication-title: Clin. Infect. Dis. doi: 10.1086/520243 contributor: fullname: McMinn – year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0675 article-title: On the origin and continuing evolution of SARS-CoV-2 publication-title: Natl. Sci. Rev. doi: 10.1093/nsr/nwaa036 contributor: fullname: Tang – volume: 30 start-page: 1434 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0225 article-title: Mapping genome variation of SARS-CoV-2 worldwide highlights the impact of COVID-19 super-spreaders publication-title: Genome Res. doi: 10.1101/gr.266221.120 contributor: fullname: Gómez-Carballa – ident: 10.1016/j.meegid.2021.104869_bb0590 contributor: fullname: Resende – ident: 10.1016/j.meegid.2021.104869_bb0775 contributor: fullname: Volz – volume: 5 start-page: 562 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0425 article-title: Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses publication-title: Nat. Microbiol. doi: 10.1038/s41564-020-0688-y contributor: fullname: Letko – volume: 19 year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0475 article-title: Natural selection in the evolution of SARS-CoV-2 in bats created a generalist virus and highly capable human pathogen publication-title: PLoS Biol. doi: 10.1371/journal.pbio.3001115 contributor: fullname: MacLean – volume: 5 start-page: 1403 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0575 article-title: A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology publication-title: Nat. Microbiol. doi: 10.1038/s41564-020-0770-5 contributor: fullname: Rambaut – year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0610 article-title: Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence publication-title: Lancet. doi: 10.1016/S0140-6736(21)00183-5 contributor: fullname: Sabino – volume: 11 start-page: 4235 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0410 article-title: Origin and cross-species transmission of bat coronaviruses in China publication-title: Nat. Commun. doi: 10.1038/s41467-020-17687-3 contributor: fullname: Latinne – volume: 12 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0140 article-title: Genomic epidemiology of the first wave of SARS-CoV-2 in Italy publication-title: Viruses doi: 10.3390/v12121438 contributor: fullname: Di Giallonardo – volume: 88 start-page: 104684 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0010 article-title: Two prolonged viremic SARS-CoV-2 infections with conserved viral genome for two months publication-title: Infect. Genet. Evol. doi: 10.1016/j.meegid.2020.104684 contributor: fullname: Abu-Raddad – year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0335 article-title: S-variant SARS-CoV-2 lineage B1.1.7 is associated with significantly higher viral loads in samples tested by ThermoFisher TaqPath RT-qPCR publication-title: J. Infect. Dis. doi: 10.1093/infdis/jiab082 contributor: fullname: Kidd – volume: 184 start-page: 1171 year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0700 article-title: Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity publication-title: Cell doi: 10.1016/j.cell.2021.01.037 contributor: fullname: Thomson – year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0135 article-title: Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation publication-title: bioRxiv contributor: fullname: Deng – year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0185 article-title: ChAdOx1 nCoV-19 (AZD1222) protects hamsters against SARS-CoV-2 B.1.351 and B.1.1.7 disease publication-title: bioRxiv contributor: fullname: Fischer – volume: 5 start-page: 536 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0095 article-title: The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 publication-title: Nat. Microbiol. doi: 10.1038/s41564-020-0695-z contributor: fullname: Coronaviridae Study Group of the International Committee on Taxonomy of Viruses – ident: 10.1016/j.meegid.2021.104869_bb0770 contributor: fullname: Vöhringer – volume: 396 start-page: 603 issue: 10251 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0840 article-title: Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study publication-title: Lancet. doi: 10.1016/S0140-6736(20)31757-8 contributor: fullname: Young – volume: 395 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0450 article-title: Secondary attack rate and superspreading events for SARS-CoV-2 publication-title: Lancet doi: 10.1016/S0140-6736(20)30462-1 contributor: fullname: Liu – volume: 83 start-page: 104351 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0730 article-title: Emergence of genomic diversity and recurrent mutations in SARS-CoV-2 publication-title: Infect. Genet. Evol. doi: 10.1016/j.meegid.2020.104351 contributor: fullname: van Dorp – ident: 10.1016/j.meegid.2021.104869_bb0290 contributor: fullname: Jackson – year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0455 article-title: Landscape analysis of escape variants identifies SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization publication-title: BioRxiv. contributor: fullname: Liu – volume: 11 start-page: 1748 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0105 article-title: Remodeling of the immune response with aging: immunosenescence and its potential impact on COVID-19 immune response publication-title: Front. Immunol. doi: 10.3389/fimmu.2020.01748 contributor: fullname: Cunha – volume: 183 start-page: 996 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0605 article-title: Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity publication-title: Cell doi: 10.1016/j.cell.2020.09.038 contributor: fullname: Rydyznski Moderbacher – volume: 9 start-page: 221 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0080 article-title: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan publication-title: Emerg. Microbes Infect. doi: 10.1080/22221751.2020.1719902 contributor: fullname: Chan – ident: 10.1016/j.meegid.2021.104869_bb0580 contributor: fullname: Rambaut – volume: 26 start-page: 1714 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0015 article-title: Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong publication-title: Nat. Med. doi: 10.1038/s41591-020-1092-0 contributor: fullname: Adam – volume: 382 start-page: 2302 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0260 article-title: Spread of SARS-CoV-2 in the Icelandic population publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2006100 contributor: fullname: Gudbjartsson – volume: 92 start-page: 1932 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0315 article-title: Understanding evolution of SARS-CoV-2: A perspective from analysis of genetic diversity of RdRp gene publication-title: J. Med. Virol. doi: 10.1002/jmv.25909 contributor: fullname: Kasibhatla – volume: 79 start-page: 1595 year: 2005 ident: 10.1016/j.meegid.2021.104869_bb0765 article-title: Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event publication-title: J. Virol. doi: 10.1128/JVI.79.3.1595-1604.2005 contributor: fullname: Vijgen – volume: 26 year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0060 article-title: Tracking SARS-CoV-2 lineage B.1.1.7 dissemination: insights from nationwide spike gene target failure (SGTF) and spike gene late detection (SGTL) data, Portugal, week 49 2020 to week 3 2021 publication-title: Euro. Surveill. doi: 10.2807/1560-7917.ES.2021.26.10.2100130 contributor: fullname: Borges – volume: 184 start-page: 64 year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0780 article-title: Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity publication-title: Cell doi: 10.1016/j.cell.2020.11.020 contributor: fullname: Volz – volume: 383 start-page: 2439 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0785 article-title: Safety and immunogenicity of two RNA-based covid-19 vaccine candidates publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2027906 contributor: fullname: Walsh – volume: 348 start-page: 1967 year: 2003 ident: 10.1016/j.meegid.2021.104869_bb0145 article-title: Identification of a novel coronavirus in patients with severe acute respiratory syndrome publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa030747 contributor: fullname: Drosten – volume: 12 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0565 article-title: Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2 publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.abe2555 contributor: fullname: Popa – year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0345 article-title: Densely sampled viral trajectories suggest longer duration of acute infection with B.1.1.7 variant relative to non-B.1.1.7 SARS-CoV-2 publication-title: bioRxiv contributor: fullname: Kissler – volume: 10 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0670 article-title: Molecular epidemiology analysis of SARS-CoV-2 strains circulating in Romania during the first months of the pandemic publication-title: Life doi: 10.3390/life10080152 contributor: fullname: Surleac – volume: 30 start-page: 3896 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0850 article-title: A novel bat coronavirus closely related to SARS-CoV-2 contains natural insertions at the S1/S2 cleavage site of the spike protein publication-title: Curr. Biol. doi: 10.1016/j.cub.2020.09.030 contributor: fullname: Zhou – volume: 16 issue: 12 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0210 article-title: Infection of human nasal epithelial cells with SARS-CoV-2 and a 382-nt deletion isolate lacking ORF8 reveals similar viral kinetics and host transcriptional profiles publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1009130 contributor: fullname: Gamage – volume: 586 start-page: 589 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0530 article-title: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults publication-title: Nature doi: 10.1038/s41586-020-2639-4 contributor: fullname: Mulligan – volume: 2 year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0495 article-title: Isolating SARS-CoV-2 strains from countries in the same meridian: genome evolutionary analysis publication-title: JMIR Bioinform. Biotech. doi: 10.2196/25995 contributor: fullname: Mastriani – start-page: 26 year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0430 article-title: Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020 publication-title: Euro. Surveill. contributor: fullname: Leung – year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0175 article-title: Genomics and epidemiology of a novel SARS-CoV-2 lineage in Manaus, Brazil publication-title: medRxiv. contributor: fullname: Faria – ident: 10.1016/j.meegid.2021.104869_bb0065 contributor: fullname: Borges – year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0555 article-title: Spike mutation D614G alters SARS-CoV-2 fitness publication-title: Nature. contributor: fullname: Plante – year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0790 article-title: mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants publication-title: bioRxiv contributor: fullname: Wang – volume: 29 start-page: 463 year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0230 article-title: Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies publication-title: Cell Host Microbe doi: 10.1016/j.chom.2021.02.003 contributor: fullname: Greaney – volume: 396 start-page: 467 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0195 article-title: Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(20)31604-4 contributor: fullname: Folegatti – volume: 9 year: 2020 ident: 10.1016/j.meegid.2021.104869_bb0005 article-title: Evidence for SARS-CoV-2 Infection of Animal Hosts publication-title: Pathogens doi: 10.3390/pathogens9070529 contributor: fullname: Abdel-Moneim – year: 2021 ident: 10.1016/j.meegid.2021.104869_bb0465 article-title: SARS-CoV-2 within-host diversity and transmission publication-title: Science doi: 10.1126/science.abg0821 contributor: fullname: Lythgoe |
SSID | ssj0017028 |
Score | 2.5354552 |
SecondaryResourceType | review_article |
Snippet | The COVID-19 pandemic was officially declared on March 11th, 2020. Since the very beginning, the spread of the virus has been tracked nearly in real-time by... The COVID-19 pandemic was officially declared on March 11 , 2020. Since the very beginning, the spread of the virus has been tracked nearly in real-time by... The COVID-19 pandemic was officially declared on March 11 th , 2020. Since the very beginning, the spread of the virus has been tracked nearly in real-time by... |
SourceID | pubmedcentral proquest crossref pubmed elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 104869 |
SubjectTerms | Biological Evolution COVID-19 COVID-19 - epidemiology COVID-19 - immunology COVID-19 - virology COVID-19 Vaccines - immunology Diagnostic tests Genetic Variation Humans Lineages Review SARS-CoV-2 SARS-CoV-2 - genetics Vaccination VACCINES Variants |
Title | One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages |
URI | https://dx.doi.org/10.1016/j.meegid.2021.104869 https://www.ncbi.nlm.nih.gov/pubmed/33915216 https://search.proquest.com/docview/2520866807 https://pubmed.ncbi.nlm.nih.gov/PMC8074502 |
Volume | 92 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9QwEA_n3Ysg4rfrxxLB17jd5qv1bVk81q9Tbj25ByEk6axX4drF2xN88W93pmkXVwXBxzYJTSeT-cjM_MLYU1VGVDqxEgQNIpSugggmn4rCm5VEDb-yHaTQ2yOzOFGvTvXpHpsPtTCUVtnL_iTTO2ndv5n01Jys63qyRM-DCiGLnGCEjEG__QDVEcVqD2YvXy-OtsEEm3VXrFJ_QQOGCrouzesc4HNNkKH5lOKdBWU-_11D_WmB_p5I-YtmOrzBrvcmJZ-lWd9ke9DcYtfSeRxPZUa32ad3DfDvyNa8bjYtR7OPr-n8-LyOz_nyDI1wQUKaw7eeF3m74svZ8VLM248i59iXQ1-qCdSG5jgnExXl0cUddnL44sN8IfqbFURURm6E8iV6oyZohbQplQ-Q6zxKb0xp0cAA3Mil8eBBywBeyyzIoK23UsdYacjkXbbftA3cZ9zndIuuLWQscP9DVaiobCRgdw-m8mHExEBNt04AGm7ILPviEvUdUd8l6o-YHUjudhjBoYz_x8gnwwo53CMU-PANtJcXDn8OPTdTZHbE7qUV285FEkJ-PjX43Z213HYg_O3dlqY-63C4CUdIZ_mD_57xQ3aVnlI-4SO2v_l6CY_RxtmEMbvy7Md0jJw8P37zftxz9E8S3ftd |
link.rule.ids | 230,314,780,784,885,4502,24116,27924,27925,45585,45679 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3daxQxEA-lPihI8dvzM4Kv8fbyuetbOSynthW8VvoghCQ7Z7fQ3cNehb70b3dmPw5PBcHXTZbNTiYzv0lmfmHstS4SOp1UCqIGEdqUUUQrJyIPdqHQwy9cSyl0cGhnx_rDiTnZYtOhFobSKnvb39n01lr3T8a9NMfLqhrPMfKgQshcEo2QtRi339AG0S8q9ZvrdZ7HxGXtBavUW1D3oX6uTfI6B_hWEWGonNBpZ055z3_3T3_iz9_TKH_xS3t32E4PKPluN-a7bAvqe-x2txvHuyKj--zrpxr4FSo1r-pVwxH08SXtHp9X6S2fnyIEF2SiOfzoNZE3Cz7f_TwX0-aLkBz7cugLNYHaEIxzAqhojS4esOO9d0fTmejvVRBJW7USOhQYi9poNMqm0CGCNDKpYG3hEF4ALuPCBghgVIRgVBZVNC44ZVIqDWTqIduumxoeMx4k3aHrcpVyXP1Q5jppl4jWPYAtQxwxMUjTLzv6DD_klZ35TvqepO876Y-YG0TuN9TAo4X_x5uvhhnyuELo2CPU0FxeePw5jNtsnrkRe9TN2Hosivjx5cTidzfmct2B2Lc3W-rqtGXhJhYhk8kn_z3il-zm7Ohg3--_P_z4lN2ili6z8BnbXn2_hOeIdlbxRavNPwGCpPqh |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=One+year+into+the+pandemic%3A+Short-term+evolution+of+SARS-CoV-2+and+emergence+of+new+lineages&rft.jtitle=Infection%2C+genetics+and+evolution&rft.au=Gonz%C3%A1lez-Candelas%2C+Fernando&rft.au=Shaw%2C+Marie-Anne&rft.au=Phan%2C+Tung&rft.au=Kulkarni-Kale%2C+Urmila&rft.date=2021-08-01&rft.pub=Elsevier+B.V&rft.issn=1567-1348&rft.eissn=1567-7257&rft.volume=92&rft_id=info:doi/10.1016%2Fj.meegid.2021.104869&rft.externalDocID=S1567134821001660 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1567-1348&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1567-1348&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1567-1348&client=summon |